2023


  1. Uhe T, Wasser K, Weber-Krüger M, Schäbitz WR, Köhrmann M, Brachmann J, Laufs U, Dichgans M, Gelbrich G, Petroff D, Prettin C, Michalski D, Kraft A, Etgen T, Schellinger PD, Soda H, Bethke F, Ertl M, Kallmünzer B, Grond M, Althaus K, Hamann GF, Mende M, Wagner M, Gröschel S, Uphaus T, Gröschel K, Wachter R (2023). Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism-the Find-AF 2 study-rationale and design. Am Heart J, 265(), 66-76.
     
  2. Eidizadeh A, Schnelle M, Leha A, Edelmann F, Nolte K, Werhahn SM, Binder L, Wachter R (2023). Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study. ESC Heart Fail, 10(1), 200-210.
     
  3. Gessner R, Gärtner C, Schmidt M, Eckelt F, Wirkner K, Löffler M, Uhe T, Isermann B, Laufs U, Kaiser T, Wachter R (2023). Higher troponin T serum concentrations in hospital patients without diagnosed cardiac diseases compared to a population-based cohort. Clin Chem Lab Med, 61(11), 2046-2052.
     
  4. Stader J, Antoniadis M, Ussat M, Wachter R, Lavall D, Metze M, Neef M, Spies C, Laufs U, Lenk K (2023). Comparison of quantitative flow ratio with instantaneous wave-free ratio and resting full-cycle ratio during daily routine in the catheterization laboratory. Catheter Cardiovasc Interv, 102(1), 91-100.
     
  5. Stürzebecher PE, Katzmann JL, Laufs U (2023). What is 'remnant cholesterol'? Eur Heart J, 44(16), 1446-1448.
     
  6. Laufs U, Blüher M, Isermann B (2023). Third generation PCSK9-inhibitors. Eur Heart J, 44(40), 4281-4283.
     
  7. Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan SR, Paschen A, Herter T, Gaul S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T (2023). Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form. Nat Immunol, 24(3), 412-413.
     
  8. Parhofer KG, Laufs U (2023). Lipid Profile and Lipoprotein(a) Testing. Dtsch Arztebl Int, 120(35-36), 582-588.
     
  9. Laufs U, Catapano AL, De Caterina R, Schiele F, Sionis A, Zaman A, Jukema JW (2023). The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project. Vascul Pharmacol, 148, 107141.
     
  10. von Eckardstein A, März W, Laufs U (2023). [HDL - Quo vadis]. Dtsch Med Wochenschr, 148(10), 627-635.
     
  11. Ueberham L, Hagendorff A, Klingel K, Paetsch I, Jahnke C, Kluge T, Ebbinghaus H, Hindricks G, Laufs U, Dinov B (2023). Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis. J Am Heart Assoc, 12(6), e027971.
     
  12. Schulz M, Trenk D, Laufs U (2023). [Cardiovascular pharmacotherapy in old age]. Herz, 48(4), 325-336.
     
  13. Katzmann JL, Laufs U (2023). Liver transplantation for homozygous familial hypercholesterolemia: Cure for a genetic disease? Atherosclerosis, 387, 117337.
     
  14. Maeder C, Speer T, Wirth A, Boeckel JN, Fatima S, Shahzad K, Freichel M, Laufs U, Gaul S (2023). Membrane-bound Interleukin-1? mediates leukocyte adhesion during atherogenesis. Front Immunol, 14, 1252384.
     
  15. Schwarzkopf L, Büttner P, Scholtyssek K, Schröter T, Hiller R, Hindricks G, Bollmann A, Laufs U, Ueberham L (2023). C-kit(pos) cells in the human left atrial appendage. Heliyon, 9(11), 21268.
     
  16. Henschke V, Hild K, Schilling E, Haas J, Filipova V, Erbe S, König R, Hübschen JM, Laufs U, Claus C, Boeckel JN (2023). Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10. iScience, 26(4), 106352.
     
  17. Kandels J, Metze M, Hagendorff A, Marshall RP, Hepp P, Laufs U, Stöbe S (2023). The impact of upright posture on left ventricular deformation in athletes. Int J Cardiovasc Imaging, 39(6), 1123-1131.
     
  18. Metze M, Siegemund A, Siegemund T, Klöter T, Stöbe S, Laufs U, Petros S, Pfrepper C (2023). The dose-response of direct oral anticoagulants is non-linear at plasma levels below 100?ng/ml. Int J Lab Hematol, 45(3), e60-e63.
     
  19. Stürzebecher PE, Schorr JJ, Klebs SHG, Laufs U (2023). Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses. Atherosclerosis, 367, 24-33.
     
  20. Stöbe S, Kandels J, Metze M, Tayal B, Laufs U, Hagendorff A (2023). Left ventricular hypertrophy, diastolic dysfunction and right ventricular load predict outcome in moderate aortic stenosis. Front Cardiovasc Med, 9, 1101493.
     
  21. Lavall D, Vosshage NH, Geßner R, Stöbe S, Ebel S, Denecke T, Hagendorff A, Laufs U (2023). Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy. Clin Res Cardiol, 112(3), 334-342.
     
  22. Kandels J, Stöbe S, Kogel A, Hepp P, Riepenhof H, Droste JN, Stoeggl T, Marshall RP, Rudolph U, Laufs U, Fikenzer S, Hagendorff A (2023). Effect of maximum exercise on left ventricular deformation and its correlation with cardiopulmonary exercise capacity in competitive athletes. Echo Res Pract, 10(1), 17.
     
  23. Metze M, Stöbe S, Pfeiffer D, Hagendorff A, Laufs U, Lenk K (2023). First case report of the use of two stents following coronary artery obstruction during indirect mitral annuloplasty. ESC Heart Fail, 10(4), 2694-2697.
     
  24. Kogel A, Machatschek M, Scharschmidt R, Wollny C, Lordick F, Ghanem M, Laufs U, Fikenzer S (2023). Physical exercise as a treatment for persisting symptoms post-COVID infection: review of ongoing studies and prospective randomized controlled training study. Clin Res Cardiol, 112(11), 1699-1709.
     
  25. Stürzebecher PE, Tünnemann-Tarr A, Tuppatsch K, Laufs U (2023). [Treatment and LDL cholesterol adjustment in patients with high and very high cardiovascular risk in Germany compared with Europe - data from the SANTORINI registry]. Dtsch Med Wochenschr, 148(9), 55-64.
     
  26. Hagendorff A, Helfen A, Brandt R, Altiok E, Breithardt O, Haghi D, Knierim J, Lavall D, Merke N, Sinning C, Stöbe S, Tschöpe C, Knebel F, Ewen S (2023). Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography. Clin Res Cardiol, 112(1), 1-38.
     
  27. Kandels J, Metze M, Hagendorff A, Stöbe S (2023). Prognostic Relevance of Global Myocardial Work Index in Patients with Moderate Aortic Valve Stenosis. J Clin Med, 12(24), 7694.
     
  28. Kandels J, Metze M, Hagendorff A, Stöbe S (2023). Impact of Aortic Valve Regurgitation on Doppler Echocardiographic Parameters in Patients with Severe Aortic Valve Stenosis. Diagnostics (Basel), 13(11), 1828.
     
  29. Hagendorff A, Kandels J, Metze M, Tayal B, Stöbe S (2023). Valid and Reproducible Quantitative Assessment of Cardiac Volumes by Echocardiography in Patients with Valvular Heart Diseases-Possible or Wishful Thinking? Diagnostics (Basel), 13(7), 1359.
     
  30. Pfrepper C, Koch E, Weise M, Siegemund R, Siegemund A, Petros S, Metze M (2023). Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients. Res Pract Thromb Haemost, 7(2), 100054.
     
  31. Zhou Q, Boeckel JN, Yao J, Zhao J, Bai Y, Lv Y, Hu M, Meng D, Xie Y, Yu P, Xi P, Xu J, Zhang Y, Dimmeler S, Xiao J (2023). Diagnosis of acute myocardial infarction using a combination of circulating circular RNA cZNF292 and clinical information based on machine learning. MedComm (2020), 4(3), e299.
     
  32. Kresoja KP, Unterhuber M, Wachter R, Thiele H, Lurz P (2023). A cardiologist's guide to machine learning in cardiovascular disease prognosis prediction. Basic Res Cardiol, 118(1), 10.
     
  33. Diener HC, Wachter R, Wong A, Thijs V, Schnabel RB, Ntaios G, Kasner S, Rothwell PM, Passman R, Saver JL, Albers BA, Bernstein RA (2023). Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke. Int J Stroke, 18(4), 400-407.
     
  34. Engel C, Wirkner K, Zeynalova S, Baber R, Binder H, Ceglarek U, Enzenbach C, Fuchs M, Hagendorff A, Henger S, Hinz A, Rauscher FG, Reusche M, Riedel-Heller SG, Röhr S, Sacher J, Sander C, Schroeter ML, Tarnok A, Treudler R, Villringer A, Wachter R, Witte AV, Thiery J, Scholz M, Loeffler M (2023). Cohort Profile: The LIFE-Adult-Study. Int J Epidemiol, 52(1), 66-79.
     
  35. Tsivgoulis G, Palaiodimou L, Triantafyllou S, Köhrmann M, Dilaveris P, Tsioufis K, Magiorkinis G, Krogias C, Schellinger PD, Caso V, Paciaroni M, Sharma M, Lemmens R, Gladstone DJ, Sanna T, Wachter R, Filippatos G, Katsanos AH (2023). Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials. Eur Stroke J, 8(1), 106-116.
     
  36. Balligand JL, Brito D, Brosteanu O, Casadei B, Depoix C, Edelmann F, Ferreira V, Filippatos G, Gerber B, Gruson D, Hasenclever D, Hellenkamp K, Ikonomidis I, Krakowiak B, Lhommel R, Mahmod M, Neubauer S, Persu A, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Pouleur AC (2023). Repurposing the ?3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical Trial. JAMA Cardiol, 8(11), 1031-1040.
     
  37. Hoffmann J, Hanß S, Kraus M, Schaller J, Schäfer C, Stahl D, Anker SD, Anton G, Bahls T, Blankenberg S, Blumentritt A, Boldt LH, Cordes S, Desch S, Doehner W, Dörr M, Edelmann F, Eitel I, Endres M, Engelhardt S, Erdmann J, Eulenburg K, Falk V, Felix SB, Frank D, Franke T, Frey N, Friede T, Geidel L, Germans L, Grabmaier U, Halle M, Hausleiter J, Jakobi V, Jebran AF, Jobs A, Kääb S, Karakas M, Katus HA, Klatt A, Knosalla C, Krebser J, Landmesser U, Lee M, Lehnert K, Lesser S, Leyh K, Lorbeer R, M (2023). The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies. Clin Res Cardiol, 112(7), 923-941.
     
  38. Kalarus Z, Mairesse GH, Sokal A, Boriani G, ?redniawa B, Casado-Arroyo R, Wachter R, Frommeyer G, Traykov V, Dagres N, Lip GYH, Boersma L, Peichl P, Dobrev D, Bulava A, Blomström-Lundqvist C, de Groot NMS, Schnabel R, Heinzel F, Van Gelder IC, Carbuccichio C, Shah D, Eckardt L (2023). Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper. Europace, 25(1), 185-198.
     
  39. Witte KK, Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Fonseca C, Lonn E, Noè A, Schwende H, Butylin D, Chiang Y, Pascual-Figal D (2023). Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure. ESC Heart Fail, 10(1), 80-89.
     
  40. Zelenak C, Nagel J, Bersch K, Derendorf L, Doyle F, Friede T, Herbeck Belnap B, Kohlmann S, Skou ST, Velasco CA, Albus C, Asendorf T, Bang CA, Beresnevaite M, Bruun NE, Burg MM, Buhl SF, Gaede PH, Lühmann D, Markser A, Nagy KV, Rafanelli C, Rasmussen S, Søndergaard J, Sørensen J, Stauder A, Stock S, Urbinati S, Riva DD, Wachter R, Walker F, Pedersen SS, Herrmann-Lingen C (2023). Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study. ESC Heart Fail, 10(3), 2051-2065.
     
  41. Schneider A, Hartman MHT, Nolte K, Werhahn SM, Wachter R, Herrmann-Lingen C (2023). Coping styles as predictors for quality of life and prognosis in patients at risk for or with a diagnosis of heart failure: Results from the observational DIAST-CHF study. J Psychosom Res, 170, 111384.
     
  42. Kerwagen F, Riemer U, Wachter R, von Haehling S, Abdin A, Böhm M, Schulz M, Störk S (2023). Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in Germany: a nationwide retrospective analysis. Lancet Reg Health Eur, 35, 100778.
     
  43. Kresoja KP, Unterhuber M, Wachter R, Rommel KP, Besler C, Shah S, Thiele H, Edelmann F, Lurz P (2023). Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials. EBioMedicine, 96, 104795.
     
  44. Lechner K, Bock M, von Schacky C, Scherr J, Lorenz E, Lechner B, Haller B, Krannich A, Halle M, Wachter R, Duvinage A, Edelmann F (2023). Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial. Clin Res Cardiol, 112(11), 1541-1554.
     
  45. Wilke MR, Broschmann D, Sandek A, Wachter R, Edelmann F, Herrmann-Lingen C (2023). Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial. BMC Cardiovasc Disord, 23(1), 184.
     
  46. Banach M, Penson PE, Farnier M, Fras Z, Latkovskis G, Laufs U, Paneni F, Parini P, Pirro M, Reiner ?, Vrablik M, Escobar C (2023). Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP). Prog Cardiovasc Dis, 79, 2-11.
     
  47. Ray KK, Haq I, Bilitou A, Manu MC, Burden A, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL (2023). Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. Lancet Reg Health Eur, 29, 100624.
     
  48. Makhmudova U, Schatz U, Perakakis N, Kassner U, Schumann F, Axthelm C, Stürzebecher P, Sinning DL, Doevelaar A, Rohn B, Westhoff T, Vogt A, Scholl M, Kästner U, Geiling JA, Stach K, Mensch J, Lorenz E, Paitazoglou C, Eitel I, Baessler A, Steinhagen-Thiessen E, Koenig W, Schulze PC, Landmesser U, Laufs U, Weingärtner O (2023). High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany. Clin Res Cardiol, 112(11), 1639-1649.
     
  49. Olma MC, Tütüncü S, Fiessler C, Kunze C, Krämer M, Steindorf-Sabath L, Jawad-Ul-Qamar M, Kirchhof P, Laufs U, Schurig J, Kraft P, Röther J, Günther A, Thomalla G, Dimitrijeski B, Nabavi DG, Veltkamp R, Heuschmann PU, Haeusler KG, Endres M (2023). In-Hospital ECG Findings, Changes in Medical Management, and Cardiovascular Outcomes in Patients With Acute Stroke or Transient Ischemic Attack. J Am Heart Assoc, 12(2), 027149.
     
  50. März W, Schmidt N, An Haack I, Dressel A, Grammer TB, Kleber ME, Baessler A, Beil FU, Gouni-Berthold I, Julius U, Kassner U, Katzmann JL, Klose G, König C, Koenig W, Koschker AC, Laufs U, Merkel M, Otte B, Parhofer KG, Hengstenberg W, Schunkert H, Stach-Jablonski K, Steinhagen-Thiessen E, Olivier CB, Hahmann H, Krzossok S, Vogt A, Müller-Wieland D, Schatz U (2023). The German CaRe high registry for familial hypercholesterolemia - Sex differences, treatment strategies, and target value attainment. Atheroscler Plus, 53, 6-15.
     
  51. Kunz M, Götzinger F, Jacobs CM, Lauder L, Ukena C, Meyer MR, Laufs U, Schulz M, Böhm M, Mahfoud F (2023). Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study. BMJ Open, 13(11), 076302.
     
  52. Gitt AK, Parhofer KG, Laufs U, März W, Paar WD, Bramlage P, Marx N (2023). Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany. Clin Res Cardiol, 112(2), 299-311.
     
  53. Ingwersen T, Olma MC, Schlemm E, Mayer C, Cheng B, Tütüncü S, Kirchhof P, Veltkamp R, Röther J, Laufs U, Nabavi DG, Ntaios G, Endres M, Haeusler KG, Thomalla G (2023). Independent external validation of a stroke recurrence score in patients with embolic stroke of undetermined source. Neurol Res Pract, 5(1), 51.
     
  54. Mahfoud F, Kieble M, Enners S, Kintscher U, Laufs U, Böhm M, Schulz M (2023). Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia. Clin Res Cardiol, 112(2), 197-202.
     
  55. Olma MC, Tütüncü S, Grittner U, Kunze C, Jawad-Ul-Qamar M, Kirchhof P, Röther J, Thomalla G, Veltkamp R, Laufs U, Nabavi DG, Heuschmann PU, Endres M, Haeusler KG (2023). Extent of routine diagnostic cardiac work-up at certified German stroke units participating in the prospective MonDAFIS study. Neurol Res Pract, 5(1), 21.
     
  56. Stroes ESG, Bays HE, Banach M, Catapano AL, Duell PB, Laufs U, Mancini GBJ, Ray KK, Sasiela WJ, Zhang Y, Gotto AM Jr (2023). Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials. Atherosclerosis, 373, 1-9.
     
  57. Stader J, Antoniadis M, Ussat M, Wachter R, Lavall D, Metze M, Neef M, Spies C, Laufs U, Lenk K (2023). Comparison of quantitative flow ratio with instantaneous wave-free ratio and resting full-cycle ratio during daily routine in the catheterization laboratory. Catheter Cardiovasc Interv, 102(1), 91-100.
     
  58. Ebbinghaus H, Ueberham L, Husser-Bollmann D, Bollmann A, Laufs U, Dinov B (2023). Case Report: Four cases of cardiac sarcoidosis in patients with inherited cardiomyopathy-a phenotypic overlap, co-existence of two rare cardiomyopathies or a second-hit disease. Front Cardiovasc Med, 10, 1328802.
     
  59. Santoro C, Donal E, Magne J, Sade LE, Penicka M, Katbeh A, Cosyns B, Cameli M, Hanzevacki JS, Luksic VR, Agricola E, Citro R, Hagendorff A, Lancellotti P, Habib G, Moreo A, Cardim N, Parato VM, Neskovic A, Rosca M, Galli E, Motoc A, Mandoli G, Ingallina G, Prota C, Stoebe S, Piette C, Mouhat B, Carbone A, Chiara B, Ilardi F, Stankovic I, Zamorano JL, Popescu BA, Edvardsen T, Galderisi M (2023). Inter-center reproducibility of standard and advanced echocardiographic parameters in the EACVI-AFib echo registry. Echocardiography, 40(8), 775-783.
     
  60. Seiffert M, Vonthein R, Baumgartner H, Borger MA, Choi YH, Falk V, Frey N, Hagendorff A, Hagl C, Hamm C, König IR, Landmesser U, Massberg S, Reichenspurner H, Thiele H, Twerenbold R, Vens M, Walther T, Ziegler A, Cremer J, Blankenberg S (2023). Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial. EuroIntervention, 19(8), 652-658.
     
  61. Desch S, Freund A, Akin I, Behnes M, Preusch MR, Zelniker TA, Skurk C, Landmesser U, Graf T, Eitel I, Fuernau G, Haake H, Nordbeck P, Hammer F, Felix SB, Hassager C, Kjærgaard J, Fichtlscherer S, Ledwoch J, Lenk K, Joner M, Steiner S, Liebetrau C, Voigt I, Zeymer U, Brand M, Schmitz R, Horstkotte J, Jacobshagen C, Pöss J, Abdel-Wahab M, Lurz P, Jobs A, de Waha S, Olbrich D, Sandig F, König IR, Brett S, Vens M, Klinge K, Thiele H (2023). Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: One-Year Outcomes of a Randomized Clinical Trial. JAMA Cardiol, 8(9), 827-834.
     
  62. Lässing J, Maudrich T, Kenville R, Uyar Z, Bischoff C, Fikenzer S, Busse M, Falz R (2023). Intensity-dependent cardiopulmonary response during and after strength training. Sci Rep, 13(1), 6632.
     
  63. Seeger J, Wöhrle J, Scheller B, Farah A, Ohlow MA, Mangner N, Möbius-Winkler S, Weilenmann D, Stachel G, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Jeger R, On Behalf Of The Basket-Small Investigators (2023). Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial. J Cardiovasc Dev Dis, 10(3), 119.
     
  64. Zhou Q, Boeckel JN, Yao J, Zhao J, Bai Y, Lv Y, Hu M, Meng D, Xie Y, Yu P, Xi P, Xu J, Zhang Y, Dimmeler S, Xiao J (2023). Diagnosis of acute myocardial infarction using a combination of circulating circular RNA cZNF292 and clinical information based on machine learning. MedComm (2020), 4, 299-299.
     
  65. Bangdiwala SI, Benz AP, Bowman L, Brandes A, Buck B, Casadei B, Chen LY, Connolly SJ, Diederichsen AJ, Diederichsen SZ, Dolovich L, Engdahl J, Engler D, Freedman B, Gibson CM, Gladstone D, Haeusler K, Halcox J, Healey JS, Hobbs R, Kaasenbrood F, Lindholt JS, Lip GYH, Lopes RD, Lubitz S, Lucassen W, Mant J, McIntyre WF, McManus D, Perez M, Quinn FR, Rosenqvist M, Sandhu R, Schnabel RB, Singer DE, Siu CWD, Smyth B, Steinhubl S, Svendsen JH, Svennberg E, Tieleman R, Turakhia M, Uittenbogaart SB, Wa (2023). Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke. Thromb Haemost, 123(3), 366-376.
     
  66. Gerhardt LMS, Kordsmeyer M, Sehner S, Güder G, Störk S, Edelmann F, Wachter R, Pankuweit S, Prettin C, Ertl G, Wanner C, Angermann CE (2023). Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages. Clin Res Cardiol, 112(7), 868-879.
     
  67. Gehlen J, Stundl A, Debiec R, Fontana F, Krane M, Sharipova D, Nelson CP, Al-Kassou B, Giel AS, Sinning JM, Bruenger CMH, Zelck CF, Koebbe LL, Braund PS, Webb TR, Hetherington S, Ensminger S, Fujita B, Mohamed SA, Shrestha M, Krueger H, Siepe M, Kari FA, Nordbeck P, Buravezky L, Kelm M, Veulemans V, Adam M, Baldus S, Laugwitz KL, Haas Y, Karck M, Mehlhorn U, Conzelmann LO, Breitenbach I, Lebherz C, Urbanski P, Kim WK, Kandels J, Ellinghaus D, Nowak-Goettl U, Hoffmann P, Wirth F, Doppler S, Lahm (2023). Elucidation of the genetic causes of bicuspid aortic valve disease. Cardiovasc Res, 119(3), 857-866.
     
  68. Pathak A, Rudolph UM, Saxena M, Zeller T, Müller-Ehmsen J, Lipsic E, Schmieder RE, Sievert H, Halbach M, Sharif F, Parise H, Fischell TA, Weber MA, Kandzari DE, Mahfoud F (2023). Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. EuroIntervention, 19(7), 602-611.
     
  69. Wachter R, Laufs U (2023). Herz und Gehirn In: Marx N, Erdmann E, Klinische Kardiologie (S. 1-13), Berlin, Heidelberg: Springer Verlag.
     


    70. 2022


  70. Wachter R, Rommel KP (2022). Hospitalization for heart failure: a window of opportunity. Eur Heart J, 43(23), 2235-2236.
     
  71. Wachter R, Weber-Krüger M, Hamann GF, Kermer P, Liman J, Mende M, Seegers J, Wasser K, Gröschel S, Uphaus T, Poppert H, Köhrmann M, Zabel M, Laufs U, Heuschmann PU, Conen D, Gröschel K (2022). Long-Term Follow-up of Enhanced Holter-Electrocardiography Monitoring in Acute Ischemic Stroke. J Stroke, 24(1), 98-107.
     
  72. Uhe T, Stegmann T, Langhammer R, Dagres N, Laufs U, Wachter R (2022). Signs of left atrial disease and 10-year risk of atrial fibrillation. PLoS One, 17(4), e0266848.
     
  73. Uhe T, Beimel S, Langhammer R, Stegmann T, Hindricks G, Laufs U, Dagres N, Wachter R (2022). Patients' attitude towards a sham-controlled trial on pulmonary vein isolation in atrial fibrillation. Clin Res Cardiol, 111(1), 114-123.
     
  74. Werhahn SM, Becker C, Mende M, Haarmann H, Nolte K, Laufs U, Zeynalova S, Löffler M, Dagres N, Husser D, Dörr M, Gross S, Felix SB, Petersmann A, Herrmann-Lingen C, Binder L, Scherer M, Hasenfuß G, Pieske B, Edelmann F, Wachter R (2022). NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials. ESC Heart Fail, 9(1), 100-109.
     
  75. Laufs U, Speer T (2022). CETP inhibitors revisited. Eur Heart J, 43(14), 1425-1427.
     
  76. Katzmann JL, Custodis F, Schirmer SH, Laufs U (2022). [Update on PCSK9 inhibition]. Herz, 47(3), 196-203.
     
  77. Laufs U, Ballantyne CM, Banach M, Bays H, Catapano AL, Duell PB, Goldberg AC, Gotto AM, Leiter LA, Ray KK, Bloedon LT, MacDougall D, Zhang Y, Mancini GBJ (2022). Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. J Clin Lipidol, 16(3), 286-297.
     
  78. Stürzebecher PE, Schumann F, Kassner U, Laufs U (2022). [Statin intolerance and statin-associated muscular pain]. Herz, 47(3), 204-211.
     
  79. Weingärtner O, Marx N, Klose G, Laufs U (2022). [Therapeutic options to reduce LDL-cholesterol beyond statins]. Dtsch Med Wochenschr, 147(15), 1001-1012.
     
  80. Baum P, Bleckwenn M, Laufs U (2022). [Diagnostics and treatment of post-covid-syndrome: a multidisciplinary approach]. MMW Fortschr Med, 164(1), 36-39.
     
  81. Laufs U, Erbel R (2022). [New standard: combination therapy for the treatment of dyslipidemia]. Herz, 47(3), 195.
     
  82. Reuser A, Koenig W, Laufs U (2022). [Lp(a) and its role in cardiovascular diseases]. Dtsch Med Wochenschr, 147(23), 1564-1570.
     
  83. Katzmann JL, Laufs U (2022). [Modern lipid-lowering drugs-A means to counter the problem of undertreatment?]. Inn Med (Heidelb), 63(12), 1316-1322.
     
  84. Stürzebecher PE, Kralisch S, Schubert MR, Filipova V, Hoffmann A, Oliveira F, Sheikh BN, Blüher M, Kogel A, Scholz M, Kokot KE, Erbe S, Kneuer JM, Ebert T, Fasshauer M, Miehle K, Laufs U, Tönjes A, Boeckel JN (2022). Leptin treatment has vasculo-protective effects in lipodystrophic mice. Proc Natl Acad Sci U S A, 119(40), e2110374119.
     
  85. Tünnemann-Tarr A, Katzmann JL, Thiery J, Laufs U (2022). [Lipoprotein apheresis : State of the art and case report of the longest HELP treatment worldwide]. Herz, 47(3), 228-235.
     
  86. Gaul S, Shahzad K, Medert R, Gadi I, Mäder C, Schumacher D, Wirth A, Ambreen S, Fatima S, Boeckel JN, Khawaja H, Haas J, Brune M, Nawroth PP, Isermann B, Laufs U, Freichel M (2022). Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis. Front Cardiovasc Med, 9(), 813215.
     
  87. Baum P, Do L, Deterding L, Lier J, Kunis I, Saur D, Classen J, Wirtz H, Laufs U (2022). Cardiac function in relation to functional status and fatigue in patients with post-COVID syndrome. Sci Rep, 12(1), 19575.
     
  88. Katzmann JL, Kieble M, Enners S, Böhm M, Mahfoud F, Laufs U, Schulz M (2022). Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012-2021. Front Cardiovasc Med, 9(), 912785.
     
  89. Zimmermann L, Laufs U, Petros S, Lenk K (2022). Outcome After Thrombolysis in Patients With Intermediate High-Risk Pulmonary Embolism: A Propensity Score Analysis. J Emerg Med, 62(3), 378-389.
     
  90. Kokot KE, Kneuer JM, John D, Rebs S, Möbius-Winkler MN, Erbe S, Müller M, Andritschke M, Gaul S, Sheikh BN, Haas J, Thiele H, Müller OJ, Hille S, Leuschner F, Dimmeler S, Streckfuss-Bömeke K, Meder B, Laufs U, Boeckel JN (2022). Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs. Basic Res Cardiol, 117(1), 32.
     
  91. Kogel A, Hepp P, Stegmann T, Tünnemann-Tarr A, Falz R, Fischer P, Mahfoud F, Laufs U, Fikenzer S (2022). Effects of surgical and FFP2 masks on cardiopulmonary exercise capacity in patients with heart failure. PLoS One, 17(8), e0269470.
     
  92. Kogel A, Fikenzer S, Uhlmann L, Opitz L, Kneuer JM, Haeusler KG, Endres M, Kratzsch J, Schwarz V, Werner C, Kalwa H, Gaul S, Laufs U (2022). Extracellular Inflammasome Particles Are Released After Marathon Running and Induce Proinflammatory Effects in Endothelial Cells. Front Physiol, 13(), 866938.
     
  93. Fikenzer S, Uhe T, Lavall D, Rudolph U, Falz R, Busse M, Hepp P, Laufs U (2022). Correction to: Response to the letter to the editor by Kampert et al. entitled "Impact of wearing a facial covering on aerobic exercise capacity in the COVID?19 Era: is it more than a feeling?". Clin Res Cardiol, 111(3), 356.
     
  94. Fikenzer S, Laufs U (2022). Correction to: Response to Letter to the editors of Hopkins et al.: Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity: the numbers do not add up. Clin Res Cardiol, 111(3), 357.
     
  95. Katzmann JL, Sorio-Vilela F, Dornstauder E, Fraas U, Smieszek T, Zappacosta S, Laufs U (2022). Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C. Clin Res Cardiol, 111(3), 243-252.
     
  96. Katzmann JL, Becker C, Bilitou A, Laufs U (2022). Simulation study on LDL cholesterol target attainment, treatment costs, and ASCVD events with bempedoic acid in patients at high and very-high cardiovascular risk. PLoS One, 17(10), e0276898.
     
  97. Hagendorff A, Stöbe S (2022). [Functional Diagnostics by Rational Echocardiography]. Dtsch Med Wochenschr, 147(9), 518-527.
     
  98. Hagendorff A, Stöbe S, Kandels J, de Boer R, Tschöpe C (2022). Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction. Herz, 47(4), 293-300.
     
  99. Hagendorff A, Stöbe S (2022). Plausible Functional Diagnostics by Rational Echocardiography in the Assessment of Valvular Heart Disease - Role of Quantitative Echocardiography in the Assessment of Mitral Regurgitation. Front Cardiovasc Med, 9(), 819915.
     
  100. Metze M, Ussat M, Stöbe S (2022). [Clinical exam of the unconscious patient]. Dtsch Med Wochenschr, 147(16), 1062-1068.
     
  101. Metze M, Platz M, Pfrepper C, Petros S (2022). [Coagulation diagnostics in the clinical routine-part 2 : Monitoring of anticoagulation treatment, new-onset thrombocytopenia and thrombophilia]. Inn Med (Heidelb), 63(7), 736-750.
     
  102. Metze M, Platz M, Pfrepper C, Petros S (2022). [Coagulation diagnostics in the clinical routine-Part 1 : Evaluation of the risk of bleeding before surgery, interventions and diagnostics in bleeding diathesis]. Inn Med (Heidelb), 63(6), 619-630.
     
  103. Katzmann JL, Cupido AJ, Laufs U (2022). Gene Therapy Targeting PCSK9. Metabolites, 12(1), 70.
     
  104. Stachel G, Abdel-Wahab M, de Waha-Thiele S, Desch S, Feistritzer HJ, Kitamura M, Farhan S, Eitel I, Kurz T, Thiele H (2022). Fractal dimension of the aortic annulus: a novel predictor of paravalvular leak after transcatheter aortic valve implantation. Int J Cardiovasc Imaging, 38(11), 2469-2478.
     
  105. Farhan S, Stachel G, Desch S, Kurz T, Feistritzer HJ, Hartung P, Eitel I, Nef H, Doerr O, Lauten A, Landmesser U, Sandri M, Holzhey D, Borger M, Ince H, Öner A, Meyer-Saraei R, Wienbergen H, Fach A, Frey N, de Waha-Thiele S, Thiele H (2022). Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and balloon-expandable valves: a post hoc analysis from the SOLVE-TAVI trial. EuroIntervention, 18(9), 759-768.
     
  106. Tina Stegmann, Kerstin Koehler, Marie Schulze, Ulrich Laufs, Friedrich Koehler, Rolf Wachter (2022). Early detection of atrial fibrillation in patients with heart failure reduces the risk of subsequent hospitalization: a subanalysis of the randomized TIM-HF2 trial European Heart Journal - Digital Health, 3, 218-227.
     
  107. Abdin A, Schulz M, Riemer U, Hadëri B, Wachter R, Laufs U, Bauersachs J, Kindermann I, Vukadinovi? D, Böhm M (2022). Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials. ESC Heart Fail, 9(6), 3737-3750.
     
  108. Tsivgoulis G, Triantafyllou S, Palaiodimou L, Grory BM, Deftereos S, Köhrmann M, Dilaveris P, Ricci B, Tsioufis K, Cutting S, Magiorkinis G, Krogias C, Schellinger PD, Dardiotis E, Rodriguez-Campello A, Cuadrado-Godia E, Aguiar de Sousa D, Sharma M, Gladstone DJ, Sanna T, Wachter R, Furie KL, Alexandrov AV, Yaghi S, Katsanos AH (2022). Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysis. Neurology, 98(19), 1942-952.
     
  109. Valerio L, Mavromanoli AC, Barco S, Abele C, Becker D, Bruch L, Ewert R, Faehling M, Fistera D, Gerhardt F, Ghofrani HA, Grgic A, Grünig E, Halank M, Held M, Hobohm L, Hoeper MM, Klok FA, Lankeit M, Leuchte HH, Martin N, Mayer E, Meyer FJ, Neurohr C, Opitz C, Schmidt KH, Seyfarth HJ, Wachter R, Wilkens H, Wild PS, Konstantinides SV, Rosenkranz S (2022). Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. Eur Heart J, 43(36), 3387-3398.
     
  110. Deichl A, Wachter R, Edelmann F (2022). Comorbidities in heart failure with preserved ejection fraction. Herz, 47(4), 301-307.
     
  111. von Haehling S, Birner C, Dworatzek E, Frantz S, Hellenkamp K, Israel CW, Kempf T, Klein HH, Knosalla C, Laufs U, Raake P, Wachter R, Hasenfuss G (2022). Travelling with heart failure: risk assessment and practical recommendations. Nat Rev Cardiol, 19(5), 302-313.
     
  112. Dilk P, Wachter R, Hindricks G (2022). Catheter ablation for atrial fibrillation: impact on mortality, morbidity, quality of life, and implications for the future. Herz, 47(2), 118-122.
     
  113. Huber C, Wachter R, Pelz J, Michalski D (2022). Current Challenges and Future Directions in Handling Stroke Patients With Patent Foramen Ovale-A Brief Review. Front Neurol, 13(), 855656.
     
  114. Kumral D, Al E, Cesnaite E, Kornej J, Sander C, Hensch T, Zeynalova S, Tautenhahn S, Hagendorf A, Laufs U, Wachter R, Nikulin V, Villringer A (2022). Attenuation of the Heartbeat-Evoked Potential in Patients With Atrial Fibrillation. JACC Clin Electrophysiol, 8(10), 1219-1230.
     
  115. Backhaus SJ, Rösel SF, Schulz A, Lange T, Hellenkamp K, Gertz RJ, Wachter R, Steinmetz M, Kutty S, Raaz U, Friede T, Seidler T, Uecker M, Hasenfuß G, Schuster A (2022). RT-CMR Imaging for Noninvasive Characterization of HFpEF: Medium-Term Outcomes of the HFpEF Stress Trial. JACC Cardiovasc Imaging, 15(5), 943-945.
     
  116. Lechner K, Scherr J, Lorenz E, Lechner B, Haller B, Krannich A, Halle M, Wachter R, Duvinage A, Edelmann F (2022). Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial. Clin Res Cardiol, 111(3), 308-321.
     
  117. Hashemi D, Mende M, Trippel TD, Petutschnigg J, Hasenfuss G, Nolte K, Herrmann-Lingen C, Feuerstein A, Langhammer R, Tschöpe C, Pieske B, Wachter R, Edelmann F (2022). Evaluation of the HFA-PEFF Score: results from the prospective DIAST-CHF cohort. ESC Heart Fail, 9(6), 4120-4128.
     
  118. Lechner K, von Schacky C, Scherr J, Lorenz E, Bock M, Lechner B, Haller B, Krannich A, Halle M, Wachter R, Duvinage A, Edelmann F (2022). Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial. Biomedicines, 10(9), 2296.
     
  119. Ray KK, Reeskamp LF, Laufs U, Banach M, Mach F, Tokgözo?lu LS, Connolly DL, Gerrits AJ, Stroes ESG, Masana L, Kastelein JJP (2022). Combination lipid-lowering therapy as first-line strategy in very high-risk patients. Eur Heart J, 43(8), 830-833.
     
  120. Ballantyne CM, Banach M, Bays HE, Catapano AL, Laufs U, Stroes ESG, Robinson P, Lei L, Ray KK (2022). Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study). Am J Cardiol, 174(), 1-11.
     
  121. Ambreen S, Fatima S, Elwakiel A, Rana R, Singh K, Gupta A, Gupta D, Khawaja H, Manoharan J, Besler C, Laufs U, Kohli S, Isermann B, Shahzad K (2022). Hypercoagulability Impairs Plaque Stability in Diabetes-Induced Atherosclerosis. Nutrients, 14(10), 1991.
     
  122. Bettink SI, Reil JC, Kazakov A, Körbel C, Millenaar D, Laufs U, Scheller B, Böhm M, Schirmer SH (2022). Inhibition of TRIF-Dependent Inflammation Decelerates Afterload-Induced Myocardial Remodeling. Biomedicines, 10(10), 2636.
     
  123. Merkel M, Müller-Wieland D, Laufs U, Parhofer KG (2022). [Triglycerides - assessment as risk factor and therapeutic goals]. Dtsch Med Wochenschr, 147(19), 1286-1295.
     
  124. Bewarder Y, Lauder L, Kulenthiran S, Schäfer O, Ukena C, Percy Marshall R, Hepp P, Laufs U, Stöbe S, Hagendorff A, Böhm M, Mahfoud F, Ewen S (2022). Global longitudinal strain differentiates physiological hypertrophy from maladaptive remodeling. Int J Cardiol Heart Vasc, 40(), 101044.
     
  125. Fatima S, Ambreen S, Mathew A, Elwakiel A, Gupta A, Singh K, Krishnan S, Rana R, Khawaja H, Gupta D, Manoharan J, Besler C, Laufs U, Kohli S, Isermann B, Shahzad K (2022). ER-Stress and Senescence Coordinately Promote Endothelial Barrier Dysfunction in Diabetes-Induced Atherosclerosis. Nutrients, 14(14), 2786.
     
  126. Boeckel JN, Möbius-Winkler M, Müller M, Rebs S, Eger N, Schoppe L, Tappu R, Kokot KE, Kneuer JM, Gaul S, Bordalo DM, Lai A, Haas J, Ghanbari M, Drewe-Boss P, Liss M, Katus HA, Ohler U, Gotthardt M, Laufs U, Streckfuss-Bömeke K, Meder B (2022). SLM2 Is A Novel Cardiac Splicing Factor Involved in Heart Failure due to Dilated Cardiomyopathy. Genomics Proteomics Bioinformatics, 20(1), 129-146.
     
  127. Wakob I, Wintsche I, Frisch A, Remane Y, Laufs U, Bertsche T, Schiek S (2022). Assessment of Patients' Views on Drug Benefits and Risks: An Interview Study with Cardiovascular Patients. Int J Clin Pract, 2022(), 6585271.
     
  128. Fischer P, Blumenauer D, Egger F, Fikenzer S, Zimmer A, Kulenthiran S, Laufs U, Bewarder Y, Böhm M, Mahfoud F (2022). Effects of Medical Face Masks on Physical Performance in Patients With Coronary Artery Disease or Hypertension. Am J Cardiol, 173(), 1-7.
     
  129. Pimentel BC, Ingwersen T, Haeusler KG, Schlemm E, Forkert ND, Rajashekar D, Mouches P, Königsberg A, Kirchhof P, Kunze C, Tütüncü S, Olma MC, Krämer M, Michalski D, Kraft A, Rizos T, Helberg T, Ehrlich S, Nabavi DG, Röther J, Laufs U, Veltkamp R, Heuschmann PU, Cheng B, Endres M, Thomalla G (2022). Association of stroke lesion shape with newly detected atrial fibrillation - Results from the MonDAFIS study. Eur Stroke J, 7(3), 230-237.
     
  130. Böhm M, Schumacher H, Werner C, Teo KK, Lonn EM, Mahfoud F, Speer T, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Laufs U, Williams B, Yusuf S, Mann JFE (2022). Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk. Cardiovasc Diabetol, 21(1), 12.
     
  131. Gitt AK, Laufs U, März W, Paar WD, Bramlage P, Marx N, Parhofer KG (2022). Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia. J Clin Med, 11(13), 3810.
     
  132. Leiter LA, Banach M, Catapano AL, Duell PB, Gotto AM Jr, Laufs U, Mancini GBJ, Ray KK, Hanselman JC, Ye Z, Bays HE (2022). Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials. Diabetes Obes Metab, 24(5), 868-880.
     
  133. Nave AH, Kaynak N, Mai K, Siegerink B, Laufs U, Heuschmann PU, Liman TG, Ebinger M, Endres M (2022). Combined Oral Triglyceride and Glucose Tolerance Test After Acute Ischemic Stroke to Predict Recurrent Vascular Events: The Berlin "Cream&Sugar" Study. Stroke, 53(8), 2512-2520.
     
  134. Satish P, Narasimhan B, Hagendorff A, Tayal B (2022). Evolving concept of dyssynchrony and its utility. J Geriatr Cardiol, 19(1), 44-51.
     
  135. Michels G, Horn R, Helfen A, Hagendorff A, Jung C, Hoffmann B, Jaspers N, Kinkel H, Greim CA, Knebel F, Bauersachs J, Busch HJ, Kiefl D, Spiel AO, Marx G, Dietrich CF (2022). [Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine as well as critical care (CEUS Acute) : Consensus statement of the DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM und DEGUM]. Anaesthesist, 71(4), 307-310.
     
  136. Ehrlich T, Hagendorff A, Abeln K, Froede L, Giebels C, Schäfers HJ (2022). Aortic cusp abnormalities in patients with trileaflet aortic valve and root aneurysm. Heart, 109(1), 55-62.
     
  137. Vincenza Polito M, De Angelis E, Hagendorff A, Puzziello A, Vigorito F, Ravera A (2022). Adrenergic Shock Presenting with Atypical Takotsubo Syndrome: The Alliance Between Levosimendan and Intraaortic Balloon Pump Against the Pheochromocytoma. Anatol J Cardiol, 26(4), 325-327.
     
  138. Michels G, Horn R, Helfen A, Hagendorff A, Jung C, Hoffmann B, Jaspers N, Kinkel H, Greim CA, Knebel F, Bauersachs J, Busch HJ, Kiefl D, Spiel AO, Marx G, Dietrich CF (2022). [Erratum to: Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine and critical care (CEUS Acute) : Consensus statement of DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM and DEGUM]. Med Klin Intensivmed Notfmed, 117, 24.
     
  139. Haertel F, Lenk K, Fritzenwanger M, Pfeifer R, Franz M, Memisevic N, Otto S, Lauer B, Weingärtner O, Kretzschmar D, Dannberg G, Westphal J, Baez L, Bogoviku J, Schulze PC, Moebius-Winkler S (2022). Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock. J Clin Med, 11(15), 4623.
     
  140. Pfrepper C, Metze M, Weise M, Koch E, Siegemund R, Siegemund A, Petros S (2022). Body weight adapted tinzaparin treatment in patients with obesity. Thromb Res, 214(), 65-67.
     
  141. Pfrepper C, Behrendt LC, Bönigk H, Siegemund T, Metze M, Franke D, Petros S, Siegemund A (2022). Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA. Int J Lab Hematol, 44(1), 193-201.
     
  142. Borchardt H, Kogel A, Kalwa H, Weirauch U, Aigner A (2022). Therapeutic miR-506-3p Replacement in Pancreatic Carcinoma Leads to Multiple Effects including Autophagy, Apoptosis, Senescence, and Mitochondrial Alterations In Vitro and In Vivo. Biomedicines, 10(7), 1692.
     
  143. Dumpies O, Kaur J, Stachel G, Kitamura M, Allali A, Landt M, Thiele H, Holzhey D, Richardt G, Abdel-Wahab M (2022). Long-Term Clinical and Echocardiographic Outcome After TAVR With the Mechanically Expanding Lotus Valve. JACC Cardiovasc Interv, 15(11), 1186-1188.
     
  144. Zeynalova S, Rillich K, Linnebank E, Stegmann T, Brosig M, Reusche M, Loeffler M (2022). Event dependent overall survival in the population-based LIFE-Adult-Study. PLoS One, 17(12), 0278069.
     
  145. Leiner J, Pellissier V, König S, Hohenstein S, Ueberham L, Nachtigall I, Meier-Hellmann A, Kuhlen R, Hindricks G, Bollmann A (2022). Machine learning-derived prediction of in-hospital mortality in patients with severe acute respiratory infection: analysis of claims data from the German-wide Helios hospital network. Respir Res, 23(1), 264.
     


    146. 2021


  146. Dörr M, Riemer U, Christ M, Bauersachs J, Bosch R, Laufs U, Neumann A, Scherer M, Störk S, Wachter R (2021). Hospitalizations for heart failure: still major differences between East and West Germany 30 years after reunification. ESC Heart Fail, 8(4), 2546-2555.
     
  147. Wachter R, Freedman B (2021). Subclinical Atrial Fibrillation and the Risk of Recurrent Ischemic Stroke. Thromb Haemost, 121(6), 697-699.
     
  148. Langhammer R, Wachter R (2021). [New treatment options of heart failure with reduced ejection fraction]. MMW Fortschr Med, 163(Suppl 1), 28-37.
     
  149. Diener HC, Wachter R (2021). [Diagnosis and treatment of acute ischemic insults]. Herz, 46(2), 195-204.
     
  150. Sadlonova M, Wasser K, Nagel J, Weber-Krüger M, Gröschel S, Uphaus T, Liman J, Hamann GF, Kermer P, Gröschel K, Herrmann-Lingen C, Wachter R (2021). Health-related quality of life, anxiety and depression up to 12 months post-stroke: Influence of sex, age, stroke severity and atrial fibrillation - A longitudinal subanalysis of the Find-AFRANDOMISED trial. J Psychosom Res, 142(), 110353.
     
  151. Stegmann T, Chu ML, Witte VA, Villringer A, Kumral D, Riedel-Heller SG, Roehr S, Hagendorff A, Laufs U, Loeffler M, Wachter R, Zeynalova S (2021). Heart failure is independently associated with white matter lesions: insights from the population-based LIFE-Adult Study. ESC Heart Fail, 8(1), 697-704.
     
  152. von Haehling S, Arzt M, Doehner W, Edelmann F, Evertz R, Ebner N, Herrmann-Lingen C, Garfias Macedo T, Koziolek M, Noutsias M, Schulze PC, Wachter R, Hasenfuß G, Laufs U (2021). Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials. Eur J Heart Fail, 23(1), 92-113.
     
  153. Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, Hummers E, Ivers N, Marsden T, Thornton A, Djuric A, Suerbaum J, von Grünhagen D, McIntyre WF, Benz AP, Wong JA, Merali F, Henein S, Nichol C, Connolly SJ, Healey JS (2021). Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial. JAMA Cardiol, 6(5), 558-567.
     
  154. Gärtner C, Langhammer R, Schmidt M, Federbusch M, Wirkner K, Löffler M, Isermann B, Laufs U, Wachter R, Kaiser T (2021). Revisited Upper Reference Limits for Highly Sensitive Cardiac Troponin T in Relation to Age, Sex, and Renal Function. J Clin Med, 10(23), 5508.
     
  155. Metze M, Klöter T, Stöbe S, Rechenberger B, Siegemund R, Siegemund T, Laufs U, Petros S, Pfrepper C (2021). Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants. Int J Lab Hematol, 43(6), 1539-1548.
     
  156. Lütjohann D, Stellaard F, Bölükbasi B, Kerksiek A, Parhofer KG, Laufs U (2021). Anti-PCSK 9 antibodies increase the ratios of the brain-specific oxysterol 24S-hydroxycholesterol to cholesterol and to 27-hydroxycholesterol in the serum. Br J Clin Pharmacol, 87(11), 4252-4261.
     
  157. Tünnemann-Tarr A, Scharnagl H, Katzmann JL, Stürzebecher P, Laufs U (2021). Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case report. Medicine (Baltimore), 100(42), e27573.
     
  158. Fikenzer S, Kogel A, Pietsch C, Lavall D, Stöbe S, Rudolph U, Laufs U, Hepp P, Hagendorff A (2021). SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players. Sci Rep, 11(1), 17798.
     
  159. Katzmann JL, Lehmann M, Tünnemann-Tarr A, An Haack I, Dressel A, März W, Laufs U (2021). Cutaneous manifestations in familial hypercholesterolaemia. Atherosclerosis, 333, 116-123.
     
  160. Fikenzer S, Laufs U (2021). Correction to: Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1-9. Advance online publication. https://doi.org/10.1007/s00392-020-01704-y. Clin Res Cardiol, 110(8), 1352.
     
  161. Lavall D, Bruns J, Stegmann T, Hagendorff A, Stöbe S, Laufs U (2021). Long-term clinical and haemodynamic results after transcatheter annuloplasty for secondary mitral regurgitation. ESC Heart Fail, 8(4), 2448-2457.
     
  162. Hofrichter P, Hagendorff A, Laufs U, Fikenzer S, Hepp P, Marshall RP, Tayal B, Stöbe S (2021). Analysis of left ventricular rotational deformation by 2D speckle tracking echocardiography: a feasibility study in athletes. Int J Cardiovasc Imaging, 37(8), 2369-2386.
     
  163. Gaul S, Schaeffer KM, Opitz L, Maeder C, Kogel A, Uhlmann L, Kalwa H, Wagner U, Haas J, Behzadi A, Pelegrin P, Boeckel JN, Laufs U (2021). Extracellular NLRP3 inflammasome particles are internalized by human coronary artery smooth muscle cells and induce pro-atherogenic effects. Sci Rep, 11(1), 15156.
     
  164. Schulz M, Schumacher PM, Schneider J, Said A, Laufs U (2021). Explosive drug information in the time of COVID-19. Can Pharm J (Ott), 154(4), 232-233.
     
  165. Katzmann JL, Mason AM, März W, Kleber ME, Niessner A, Blüher M, Speer T, Laufs U (2021). Genetic Variation in Sodium-glucose Cotransporter 2 and Heart Failure. Clin Pharmacol Ther, 110(1), 149-158.
     
  166. Fikenzer S, Fikenzer K, Laufs U, Falz R, Pietrek H, Hepp P (2021). Impact of COVID-19 lockdown on endurance capacity of elite handball players. J Sports Med Phys Fitness, 61(7), 977-982.
     
  167. Busch C, Katzmann JL, Jochmann C, Unterlauft JD, Vollhardt D, Wiedemann P, Laufs U, Rehak M (2021). General health of patients with diabetic macular edema-The LIPSIA study. PLoS One, 16(6), e0252321.
     
  168. Eschenhagen T, Laufs U (2021). Statins Do More Than Lower Cholesterol-Depending on What You Eat? Circulation, 143(18), 1793-1796.
     
  169. Villringer A, Laufs U (2021). Heart failure, cognition, and brain damage. Eur Heart J, 42(16), 1579-1581.
     
  170. Jurisch D, Laufs U (2021). [Chronic coronary syndrome : New classification of stable coronary artery disease]. Internist (Berl), 62(1), 47-57.
     
  171. Koehler J, Stengel A, Hofmann T, Wegscheider K, Koehler K, Sehner S, Rose M, Deckwart O, Anker SD, Koehler F, Laufs U (2021). Telemonitoring in patients with chronic heart failure and moderate depressed symptoms: results of the Telemedical Interventional Monitoring in Heart Failure (TIM-HF) study. Eur J Heart Fail, 23(1), 186-194.
     
  172. Herrmann-Lingen C, Wachter R (2021). Psychological stress and incidence of atrial fibrillation. Eur J Prev Cardiol, 28, 631-632.
     
  173. Hagendorff A, Knebel F, Helfen A, Stöbe S, Haghi D, Ruf T, Lavall D, Knierim J, Altiok E, Brandt R, Merke N, Ewen S (2021). Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness. Clin Res Cardiol, 110(11), 1704-1733.
     
  174. Stöbe S, Tayal B, Tünnemann-Tarr A, Hagendorff A (2021). Dynamics in myocardial deformation as an indirect marker of myocardial involvement in acute myocarditis due to HIV infection: a case report. Eur Heart J Case Rep, 5(2), ytaa511.
     
  175. Hagendorff A, Knebel F, Helfen A, Stöbe S, Doenst T, Falk V (2021). Disproportionate mitral regurgitation: another myth? A critical appraisal of echocardiographic assessment of functional mitral regurgitation. Int J Cardiovasc Imaging, 37(1), 183-196.
     
  176. Lavall D, Stöbe S (2021). Myocardial Function in Secondary Mitral Regurgitation: A Challenging Relationship. Circ Cardiovasc Imaging, 14(9), e013350.
     
  177. Spies C, Neef M (2021). [Ablation of a para-Hisian accessory pathway with high-power short-duration]. Herzschrittmacherther Elektrophysiol, 32(1), 128-132.
     
  178. Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, Pelegrin P, Laufs U, Feldstein AE (2021). Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol, 74(1), 156-167.
     
  179. Trippel TD, Mende M, Düngen HD, Hashemi D, Petutschnigg J, Nolte K, Herrmann-Lingen C, Binder L, Hasenfuss G, Pieske B, Wachter R, Edelmann F (2021). The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study. ESC Heart Fail, 8, 829-841.
     
  180. Schunk SJ, Kleber ME, März W, Pang S, Zewinger S, Triem S, Ege P, Reichert MC, Krawczyk M, Weber SN, Jaumann I, Schmit D, Sarakpi T, Wagenpfeil S, Kramann R, Boerwinkle E, Ballantyne CM, Grove ML, Tragante V, Pilbrow AP, Richards AM, Cameron VA, Doughty RN, Dubé MP, Tardif JC, Feroz-Zada Y, Sun M, Liu C, Ko YA, Quyyumi AA, Hartiala JA, Tang WHW, Hazen SL, Allayee H, McDonough CW, Gong Y, Cooper-DeHoff RM, Johnson JA, Scholz M, Teren A, Burkhardt R, Martinsson A, Smith JG, Wallentin L, James SK, (2021). Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. Eur Heart J, 42, 1742-1756.
     
  181. Rudolph UM, Enners S, Kieble M, Mahfoud F, Böhm M, Laufs U, Schulz M (2021). Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany. J Hum Hypertens, 35, 903-911.
     
  182. Hagendorff A, Helfen A, Flachskampf FA, Ewen S, Sebastian Kruck S, La Rosee K, Knierim J, Voigt JU, Kreidel F, Fehske W, Brandt R, Zahn R, Knebel F (2021). Manual on indications and performance of specific echocardiographic applications Kardiologe, 15, 595-641.
     
  183. Hoppe LJ, Markel F, Michaelis A, Weidenbach M, Daehnert I, et al (2021). Influence of Ventricular Ectopic Beats in Patients with Congenital Heart Disease. J Card Cardi Sur, 1, 1-14.
     
  184. Schlunk F, Fischer P, Princen HMG, Rex A, Prinz V, Foddis M, Lütjohann D, Laufs U, Endres M (2021). No effects of PCSK9-inhibitor treatment on spatial learning, locomotor activity, and novel object recognition in mice. Behav Brain Res, 396(), 112875.
     
  185. Nagel J, Chavanon ML, Binder L, Pieper A, Wachter R, Edelmann F, Herrmann-Lingen C (2021). How family history of premature myocardial infarction affects patients at cardiovascular risk. Health Psychol, 40(11), 754-763.
     
  186. Beismann C, Nolte K, Wachter R, Hashemi D, Trippel T, Edelmann F, Meyer T (2021). [The importance of health-related quality of life at baseline in predicting event-free survival in patients with a cardiovascular risk profile]. Z Psychosom Med Psychother, 67(4), 361-380.
     
  187. Bahit MC, Sacco RL, Easton JD, Meyerhoff J, Cronin L, Kleine E, Grauer C, Brueckmann M, Diener HC, Lopes RD, Brainin M, Lyrer P, Wachter R, Segura T, Granger CB (2021). Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial. Circulation, 144(22), 1738-1746.
     
  188. Gärtner C, Langhammer R, Schmidt M, Federbusch M, Wirkner K, Löffler M, Isermann B, Laufs U, Wachter R, Kaiser T (2021). Revisited Upper Reference Limits for Highly Sensitive Cardiac Troponin T in Relation to Age, Sex, and Renal Function. J Clin Med, 10(23), 5508.
     
  189. Pieske B, Wachter R, Shah SJ, Baldridge A, Szeczoedy P, Ibram G, Shi V, Zhao Z, Cowie MR (2021). Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial. JAMA, 326(19), 1919-1929.
     
  190. Schnelle M, Leha A, Eidizadeh A, Fuhlrott K, Trippel TD, Hashemi D, Toischer K, Wachter R, Herrmann-Lingen C, Hasenfuß G, Pieske B, Binder L, Edelmann F (2021). Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial. Cells, 10(10), 2796.
     
  191. Kresoja KP, Rommel KP, Wachter R, Henger S, Besler C, Klöting N, Schnelle M, Hoffmann A, Büttner P, Ceglarek U, Thiele H, Scholz M, Edelmann F, Blüher M, Lurz P (2021). Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction. Eur J Heart Fail, 23(10), 1633-1644.
     
  192. Shah SJ, Cowie MR, Wachter R, Szecsödy P, Shi V, Ibram G, Hu M, Zhao Z, Gong J, Pieske B (2021). Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction. Eur J Heart Fail, 23(9), 1541-1551.
     
  193. Schach C, Körtl T, Wachter R, Maier LS, Sossalla S (2021). Echocardiographic Evaluation of LV Function in Patients with Tachyarrhythmia and Reduced Left Ventricular Function in Response to Rhythm Restoration. J Clin Med, 10(16), 3706.
     
  194. Jorbenadze A, Fudim M, Mahfoud F, Adamson PB, Bekfani T, Wachter R, Sievert H, Ponikowski PP, Cleland JGF, Anker SD (2021). Extra-cardiac targets in the management of cardiometabolic disease: Device-based therapies. ESC Heart Fail, 8(4), 3327-3338.
     
  195. Leitsmann C, Uhlig A, Popeneciu IV, Boos M, Ahyai SA, Schmid M, Wachter R, Trojan L, Friedrich M (2021). The Silent Operation Theatre Optimisation System (SOTOS©) to reduce noise pollution during da Vinci robot-assisted laparoscopic radical prostatectomy. J Robot Surg, 15(4), 519-527.
     
  196. Eidizadeh A, Fraune L, Leha A, Wachter R, Asif AR, Binder L (2021). Inconsistent Findings of Cardiac Troponin T and I in Clinical Routine Diagnostics: Factors of Influence. J Clin Med, 10(14), 3148.
     
  197. Schnabel RB, Camen S, Knebel F, Hagendorff A, Bavendiek U, Böhm M, Doehner W, Endres M, Gröschel K, Goette A, Huttner HB, Jensen C, Kirchhof P, Korosoglou G, Laufs U, Liman J, Morbach C, Nabavi DG, Neumann-Haefelin T, Pfeilschifter W, Poli S, Rizos T, Rolf A, Röther J, Schäbitz WR, Steiner T, Thomalla G, Wachter R, Haeusler KG (2021). Expert opinion paper on cardiac imaging after ischemic stroke. Clin Res Cardiol, 110(7), 938-958.
     
  198. Haeusler KG, Kirchhof P, Kunze C, Tütüncü S, Fiessler C, Malsch C, Olma MC, Jawad-Ul-Qamar M, Krämer M, Wachter R, Michalski D, Kraft A, Rizos T, Gröschel K, Thomalla G, Nabavi DG, Röther J, Laufs U, Veltkamp R, Heuschmann PU, Endres M (2021). Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study. Lancet Neurol, 20(6), 426-436.
     
  199. Valerio L, Barco S, Jankowski M, Rosenkranz S, Lankeit M, Held M, Gerhardt F, Bruch L, Ewert R, Faehling M, Freise J, Ghofrani HA, Grünig E, Halank M, Hoeper MM, Klok FA, Leuchte HH, Mayer E, Meyer FJ, Neurohr C, Opitz C, Schmidt KH, Seyfarth HJ, Trudzinski F, Wachter R, Wilkens H, Wild PS, Konstantinides SV (2021). Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort Study. Chest, 159(6), 2428-2438.
     
  200. Schmidt C, Benda S, Kraft P, Wiedmann F, Pleger S, Büscher A, Thomas D, Wachter R, Schmid C, Eils R, Katus HA, Kallenberger SM (2021). Prospective multicentric validation of a novel prediction model for paroxysmal atrial fibrillation. Clin Res Cardiol, 110(6), 868-876.
     
  201. Lerchbaumer MH, Ebner M, Ritter CO, Steimke L, Rogge NIJ, Sentler C, Thielmann A, Hobohm L, Keller K, Lotz J, Hasenfuß G, Wachter R, Hamm B, Konstantinides SV, Aviram G, Lankeit M (2021). Prognostic value of right atrial dilation in patients with pulmonary embolism. ERJ Open Res, 7(2), 00414.
     
  202. Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, Hummers E, Ivers N, Marsden T, Thornton A, Djuric A, Suerbaum J, von Grünhagen D, McIntyre WF, Benz AP, Wong JA, Merali F, Henein S, Nichol C, Connolly SJ, Healey JS (2021). Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial. JAMA Cardiol, 6(5), 558-567.
     
  203. Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, Elkind MSV, Pouliot E, Ziegler PD (2021). Relation of Antecedent Symptoms to the Likelihood of Detecting Subclinical Atrial Fibrillation With Inserted Cardiac Monitors. Am J Cardiol, 145(), 64-68.
     
  204. Backhaus SJ, Lange T, George EF, Hellenkamp K, Gertz RJ, Billing M, Wachter R, Steinmetz M, Kutty S, Raaz U, Lotz J, Friede T, Uecker M, Hasenfuß G, Seidler T, Schuster A (2021). Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress Trial. Circulation, 143(15), 1484-1498.
     
  205. Trippel TD, Mende M, Düngen HD, Hashemi D, Petutschnigg J, Nolte K, Herrmann-Lingen C, Binder L, Hasenfuss G, Pieske B, Wachter R, Edelmann F (2021). The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study. ESC Heart Fail, 8(2), 829-841.
     
  206. Renda G, Pecen L, Patti G, Ricci F, Kotecha D, Siller-Matula JM, Schnabel RB, Wachter R, Sellal JM, Rohla M, Lucerna M, Huber K, Verheugt FWA, Zamorano JL, Brüggenjürgen B, Darius H, Duytschaever M, Le Heuzey JY, Schilling RJ, Kirchhof P, De Caterina R (2021). Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry. Intern Emerg Med, 16(3), 591-599.
     
  207. Kitsiou A, Zuhorn F, Wachter R, Israel CW, Schäbitz WR, Rogalewski A (2021). [Embolic stroke of undetermined source (ESUS) - Classification of a new stroke entity]. Dtsch Med Wochenschr, 146(6), 403-409.
     
  208. Elkind MSV, Wachter R, Verma A, Kowey PR, Halperin JL, Gersh BJ, Ziegler PD, Pouliot E, Franco N, Reiffel JA (2021). Use of the HAVOC Score to Identify Patients at Highest Risk of Developing Atrial Fibrillation. Cardiology, 146(5), 633-640.
     
  209. Desch S, Freund A, Akin I, Behnes M, Preusch MR, Zelniker TA, Skurk C, Landmesser U, Graf T, Eitel I, Fuernau G, Haake H, Nordbeck P, Hammer F, Felix SB, Hassager C, Engstrøm T, Fichtlscherer S, Ledwoch J, Lenk K, Joner M, Steiner S, Liebetrau C, Voigt I, Zeymer U, Brand M, Schmitz R, Horstkotte J, Jacobshagen C, Pöss J, Abdel-Wahab M, Lurz P, Jobs A, de Waha-Thiele S, Olbrich D, Sandig F, König IR, Brett S, Vens M, Klinge K, Thiele H (2021). Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation. N Engl J Med, 385(27), 2544-2553.
     
  210. Bertero E, Nickel A, Kohlhaas M, Hohl M, Sequeira V, Brune C, Schwemmlein J, Abeßer M, Schuh K, Kutschka I, Carlein C, Münker K, Atighetchi S, Müller A, Kazakov A, Kappl R, von der Malsburg K, van der Laan M, Schiuma AF, Böhm M, Laufs U, Hoth M, Rehling P, Kuhn M, Dudek J, von der Malsburg A, Prates Roma L, Maack C (2021). Loss of Mitochondrial Ca2+ Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy. Circulation, 144(21), 1694-1713.
     
  211. Enners S, Gradl G, Kieble M, Böhm M, Laufs U, Schulz M (2021). Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. Pharmacoepidemiol Drug Saf, 30(11), 1493-1503.
     
  212. Schumacher PM, Becker N, Tsuyuki RT, Griese-Mammen N, Koshman SL, McDonald MA, Bouvy M, Rutten FH, Laufs U, Böhm M, Schulz M (2021). The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta-analysis. ESC Heart Fail, 8(5), 3566-3576.
     
  213. Rudolph UM, Enners S, Kieble M, Mahfoud F, Böhm M, Laufs U, Schulz M (2021). Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany. J Hum Hypertens, 35(10), 903-911.
     
  214. Gjermeni E, Kirstein AS, Kolbig F, Kirchhof M, Bundalian L, Katzmann JL, Laufs U, Blüher M, Garten A, Le Duc D (2021). Obesity-An Update on the Basic Pathophysiology and Review of Recent Therapeutic Advances. Biomolecules, 11(10), 1426.
     
  215. Schunk SJ, Triem S, Schmit D, Zewinger S, Sarakpi T, Becker E, Hütter G, Wrublewsky S, Küting F, Hohl M, Alansary D, Prates Roma L, Lipp P, Möllmann J, Lehrke M, Laschke MW, Menger MD, Kramann R, Boor P, Jahnen-Dechent W, März W, Böhm M, Laufs U, Niemeyer BA, Fliser D, Ampofo E, Speer T (2021). Interleukin-1? Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease. Circulation, 144(11), 893-908.
     
  216. Schumacher PM, Griese-Mammen N, Schneider J, Laufs U, Schulz M (2021). Interdisciplinary Physician-Pharmacist Medication Review for Outpatients With Heart Failure: A Subanalysis of the PHARM-CHF Randomized Controlled Trial. Front Pharmacol, 12, 712490.
     
  217. Packard C, Chapman MJ, Sibartie M, Laufs U, Masana L (2021). Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges. Heart, 107(17), 1369-1375.
     
  218. Zimmer S, Goody PR, Oelze M, Ghanem A, Mueller CF, Laufs U, Daiber A, Jansen F, Nickenig G, Wassmann S (2021). Inhibition of Rac1 GTPase Decreases Vascular Oxidative Stress, Improves Endothelial Function, and Attenuates Atherosclerosis Development in Mice. Front Cardiovasc Med, 8, 680775.
     
  219. Hohneck AL, Fries P, Stroeder J, Schneider G, Schirmer SH, Reil JC, Böhm M, Laufs U, Custodis F (2021). Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome. Int J Cardiol Heart Vasc, 34, 100757.
     
  220. Neumann J, Voss R, Laufs U, Werner C, Gergs U (2021). Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H2-histamine-receptor activation in isolated atria of transgenic mice. Naunyn Schmiedebergs Arch Pharmacol, 394(6), 1215-1229.
     
  221. Schunk SJ, Kleber ME, März W, Pang S, Zewinger S, Triem S, Ege P, Reichert MC, Krawczyk M, Weber SN, Jaumann I, Schmit D, Sarakpi T, Wagenpfeil S, Kramann R, Boerwinkle E, Ballantyne CM, Grove ML, Tragante V, Pilbrow AP, Richards AM, Cameron VA, Doughty RN, Dubé MP, Tardif JC, Feroz-Zada Y, Sun M, Liu C, Ko YA, Quyyumi AA, Hartiala JA, Tang WHW, Hazen SL, Allayee H, McDonough CW, Gong Y, Cooper-DeHoff RM, Johnson JA, Scholz M, Teren A, Burkhardt R, Martinsson A, Smith JG, Wallentin L, James SK, (2021). Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. Eur Heart J, 42(18), 1742-1756.
     
  222. Thiele H, Freund A, Gimenez MR, de Waha-Thiele S, Akin I, Pöss J, Feistritzer HJ, Fuernau G, Graf T, Nef H, Hamm C, Böhm M, Lauten A, Schulze PC, Voigt I, Nordbeck P, Felix SB, Abel P, Baldus S, Laufs U, Lenk K, Landmesser U, Skurk C, Pieske B, Tschöpe C, Hennersdorf M, Wengenmayer T, Preusch M, Maier LS, Jung C, Kelm M, Clemmensen P, Westermann D, Seidler T, Schieffer B, Rassaf T, Mahabadi AA, Vasa-Nicotera M, Meincke F, Seyfarth M, Kersten A, Rottbauer W, Boekstegers P, Muellenbach R, Dengler (2021). Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial. Am Heart J, 234, 1-11.
     
  223. Schlunk F, Fischer P, Princen HMG, Rex A, Prinz V, Foddis M, Lütjohann D, Laufs U, Endres M (2021). No effects of PCSK9-inhibitor treatment on spatial learning, locomotor activity, and novel object recognition in mice. Behav Brain Res, 396, 112875.
     
  224. Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, Pelegrin P, Laufs U, Feldstein AE (2021). Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol, 74(1), 156-167.
     
  225. Tayal B, Freeman P, Ericsson F, Kragholm KH, Andersen NH, Hagendorff A, Aaroe J, Sogaard P, Zaremba T (2021). Characterisation of patients with and without cardiac magnetic resonance imaging abnormalities presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA). Acta Cardiol, 76(7), 760-768.
     
  226. Hedwig F, Nemchyna O, Stein J, Knosalla C, Merke N, Knebel F, Hagendorff A, Schoenrath F, Falk V, Knierim J (2021). Myocardial Work Assessment for the Prediction of Prognosis in Advanced Heart Failure. Front Cardiovasc Med, 8, 691611.
     
  227. Nechwatal RM, Bestehorn K, Leuschner F, Hagendorff A, Guha M, Schlitt A (2021). [Postacute care after transcatheter aortic valve implantation (TAVI)]. Herz, 46(1), 41-47.
     
  228. Nemchyna O, Soltani S, Solowjowa N, Schoenrath F, Hrytsyna Y, Unbehaun A, Kempfert J, Stein J, Knosalla C, Hagendorff A, Knebel F, Falk V, Knierim J (2021). Validity of visual assessment of aortic valve morphology in patients with aortic stenosis using two-dimensional echocardiography. Int J Cardiovasc Imaging, 37(3), 813-823.
     
  229. Reil JC, Reil GH, Hecker N, Sequeira V, Borer JS, Stierle U, Lavall D, Marquetand C, Busch C, Patzelt J, Heringlake M, Schäfers HJ, Sievers HH, Ensminger S, Aboud A (2021). Reduced left ventricular contractility, increased diastolic operant stiffness and high energetic expenditure in patients with severe aortic regurgitation without indication for surgery. Interact Cardiovasc Thorac Surg, 32(1), 29-38.
     
  230. Liang N, Hennebelle M, Gaul S, Johnson CD, Zhang Z, Kirpich IA, McClain CJ, Feldstein AE, Ramsden CE, Taha AY (2021). Feeding mice a diet high in oxidized linoleic acid metabolites does not alter liver oxylipin concentrations. Prostaglandins Leukot Essent Fatty Acids, 172, 102316.
     
  231. Cybularz M, Wydra S, Berndt K, Poitz DM, Barthel P, Alkouri A, Heidrich FM, Ibrahim K, Jellinghaus S, Speiser U, Linke A, Christoph M, Pfluecke C (2021). Frailty is associated with chronic inflammation and pro-inflammatory monocyte subpopulations. Exp Gerontol, 149, 111317.
     
  232. Fitz J, Edelmann F, Hasenfuß G, Sandek A, Nolte K, Hashemi D, Trippel TD, Wachter R, Herrmann-Lingen C (2021). Influence of baseline parameters on one-year physical, mental, and health-related quality of life in patients with heart failure and preserved ejection fraction. ESC Heart Fail, 8, 4635-4643.
     
  233. Antonio J Vallejo-Vaz, Christophe A T Stevens, Alexander R M Lyons, Kanika I Dharmayat, Tomas Freiberger, G Kees Hovingh, Pedro Mata, Frederick J Raal, Raul D Santos, Handrean Soran, Gerald F Watts, Marianne Abifadel, Carlos A Aguilar-Salinas, Khalid F Alhabib, Mutaz Alkhnifsawi, Wael Almahmeed, Fahad Alnouri, Rodrigo Alonso, Khalid Al-Rasadi, Ahmad Al-Sarraf, Nasreen Al-Sayed, Francisco Araujo, Tester F Ashavaid, Maciej Banach, Sophie Béliard, Marianne Benn, Christoph J Binder, Martin P Bogsrud (2021). Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet, 398(10312), 1713-1725.
     
  234. Liang N, Hennebelle M, Gaul S, Johnson CD, Zhang Z, Kirpich IA, McClain CJ, Feldstein AE, Ramsden CE, Taha AY (2021). Feeding mice a diet high in oxidized linoleic acid metabolites does not alter liver oxylipin concentrations. Prostaglandins Leukot Essent Fatty Acids, 172, 102316.
     


    235. 2020


  235. Polito MV, Citro R, Galasso G, Hagendorff A (2020). Analysis of Regional Right Ventricular Function by Tissue Doppler Imaging and Three-Dimensional Echocardiography in Highly Trained Athletes. J Cardiovasc Echogr, 30(3), 146-153.
     
  236. Stöbe S, Richter S, Seige M, Stehr S, Laufs U, Hagendorff A (2020). Echocardiographic characteristics of patients with SARS-CoV-2 infection. Clin Res Cardiol, 109(12), 1549-1566.
     
  237. Döbel T, Stöbe S, Marshall RP, Hepp P, Fikenzer S, Fikenzer K, Tautenhahn S, Laufs U, Hagendorff A (2020). Possible new options and benefits to detect myocarditis, right ventricular remodeling and coronary anomalies by echocardiography in systematic preparticipation screening of athletes. Int J Cardiovasc Imaging, 36(10), 1855-1885.
     
  238. Stöbe S, Kreyer K, Jurisch D, Pfeiffer D, Lavall D, Farese G, Laufs U, Hagendorff A (2020). Echocardiographic analysis of acute effects of percutaneous mitral annuloplasty on severity of secondary mitral regurgitation. ESC Heart Fail, 7(4), 1645-1652.
     
  239. Katzmann JL, Gouni-Berthold I, Laufs U (2020). PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects. Front Physiol, 11(), 595819.
     
  240. Fikenzer S, Laufs U (2020). Response to Letter to the editors of Hopkins et al.: Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity: the numbers do not add up. Clin Res Cardiol, 109(12), 1607.
     
  241. Fikenzer S, Laufs U (2020). Response to Letter to the editors referring to Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinical research in cardiology: official journal of the German Cardiac Society, 1-9. Advance online publication. https://doi.org/10.1007/s00392-020-01704-y. Clin Res Cardiol, 109(12), 1600.
     
  242. Laufs U, Isermann B (2020). Statin intolerance: myths and facts. Eur Heart J, 41(35), 3343-3345.
     
  243. Custodis F, Schwarzkopf K, Weimann R, Spüntrup E, Böhm M, Laufs U (2020). A SARS-Cov2-negative corona victim. Clin Res Cardiol, 109(12), 1569-1572.
     
  244. Parhofer KG, Laufs U (2020). In Reply. Dtsch Arztebl Int, 117(13), 224.
     
  245. Pfeiffer D, Monsuez JJ, Grüntzig JW, Laufs U (2020). Coronary Balloon Angioplasty is due to two physicians born in Saxony, Germany. Eur Heart J, 41(15), 1462-1463.
     
  246. Mühleck F, Laufs U (2020). Erratum zu: Primärprävention der koronaren Herzkrankheit : Evidenzbasierte medikamentöse Therapie. Herz, 45(2), 199-200.
     
  247. Schwarzbach V, Lenk K, Laufs U (2020). Methamphetamine-related cardiovascular diseases. ESC Heart Fail, 7(2), 407-414.
     
  248. Lavall D, Kuprat LK, Kandels J, Stöbe S, Hagendorff A, Laufs U (2020). Left ventricular mechanical dispersion in flow-gradient patterns of severe aortic stenosis with narrow QRS complex. Int J Cardiovasc Imaging, 36(4), 605-614.
     
  249. Mühleck F, Laufs U (2020). [Primary prevention of coronary heart disease : Evidence-based drug treatment]. Herz, 45(1), 39-49.
     
  250. Laufs U, Parhofer KG, Ginsberg HN, Hegele RA (2020). Clinical review on triglycerides. Eur Heart J, 41(1), 99-109c.
     
  251. Schulz M, Griese-Mammen N, Böhm M, Laufs U (2020). Letter on 'Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial': reply. Eur J Heart Fail, 22(3), 565-566.
     
  252. Wachter R, Klebs S, Balas B, Kap E, Engelhard J, Schlienger R, Bruce Wirta S, Fonseca AF (2020). Heart failure signs and symptoms, hospital referrals, and prescription patterns in patients receiving sacubitril/valsartan in primary care and cardiologist settings in Germany. ESC Heart Fail, 7(5), 2318-2330.
     
  253. Werhahn SM, Wachter R (2020). [Update on the diagnosis of HFrEF and HFpEF]. Dtsch Med Wochenschr, 145(19), 1369-1376.
     
  254. Uhe T, Hagendorff A, Wachter R, Laufs U (2020). Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy. Clin Res Cardiol, 109(12), 1588-1594.
     
  255. Stegmann T, Koehler K, Wachter R, Moeller V, Zeynalova S, Koehler F, Laufs U (2020). Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM-HF2 trial. ESC Heart Fail, 7(5), 2516-2526.
     
  256. Wachter R, Shah SJ, Cowie MR, Szecsödy P, Shi V, Ibram G, Zhao Z, Gong J, Klebs S, Pieske B (2020). Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial. ESC Heart Fail, 7(3), 856-864.
     
  257. Wasser K, Weber-Krüger M, Gröschel S, Uphaus T, Liman J, Hamann GF, Kermer P, Seegers J, Binder L, Gelbrich G, Gröschel K, Wachter R (2020). Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke: A Subanalysis of the Find-AFRANDOMISED Trial. Stroke, 51(2), 395-401.
     
  258. Fikenzer S, Fikenzer K, Laufs U, Falz R, Schulze A, Busse M (2020). Effects of cardioselective beta-blockade on plasma catecholamines and performance during different forms of exercise. J Sports Med Phys Fitness, 60(4), 643-649.
     
  259. Fikenzer S, Uhe T, Lavall D, Rudolph U, Falz R, Busse M, Hepp P, Laufs U (2020). Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clin Res Cardiol, 109(12), 1522-1530.
     
  260. Lenk K, Schwarzbach V, Antoniadis M, Blum M, Zeynalova S, Hagendorff A, Leistner D, Landmesser U, Lavall D, Laufs U (2020). Angiography-based quantitative coronary contrast-flow ratio measurements correlate with myocardial ischemia assessed by stress MRI. Int J Cardiovasc Imaging, 36(8), 1407-1416.
     
  261. Kandels J, Tayal B, Hagendorff A, Lavall D, Laufs U, Sogaard P, Andersen NH, Stöbe S (2020). "Pure" severe aortic stenosis without concomitant valvular heart diseases: echocardiographic and pathophysiological features. Int J Cardiovasc Imaging, 36(10), 1917-1929.
     
  262. Lenk K, Schwarzbach V, Antoniadis M, Blum M, Zeynalova S, Hagendorff A, Leistner D, Landmesser U, Lavall D, Laufs U (2020). Angiography-based quantitative coronary contrast-flow ratio measurements correlate with myocardial ischemia assessed by stress MRI. Int J Cardiovasc Imaging, 36(8), 1407-1416.
     
  263. Platz MR, Stöbe S, Baum P, Metze M (2020). Case report: isolated pulmonary valve endocarditis in a 39-year-old patient with intravenous drug abuse. Eur Heart J Case Rep, 4(6), 1-6.
     
  264. Metze M, Pfrepper C, Klöter T, Stöbe S, Siegemund R, Siegemund T, Edel E, Laufs U, Petros S (2020). Inhibition of thrombin generation 12 hours after intake of direct oral anticoagulants. Res Pract Thromb Haemost, 4(4), 610-618.
     
  265. Tünnemann-Tarr A, Stöbe S, Laufs U, Hagendorff A, Tayal B (2020). Speckle tracking echocardiography in a patient with viral myocarditis and acute myocardial infarction. J Cardiol Cases, 22(4), 184-191.
     
  266. Katzmann JL, Packard CJ, Chapman MJ, Katzmann I, Laufs U (2020). Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art Review. J Am Coll Cardiol, 76(5), 563-579.
     
  267. Katzmann JL, Werner CM, Stojakovic T, März W, Scharnagl H, Laufs U (2020). Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study. Lipids Health Dis, 19(1), 116.
     
  268. Katzmann JL, Schlattmann P, Rigopoulos AG, Noutsias E, Bigalke B, Pauschinger M, Tschope C, Sedding D, Schulze PC, Noutsias M (2020). Meta-analysis on the immunohistological detection of inflammatory cardiomyopathy in endomyocardial biopsies. Heart Fail Rev, 25(2), 277-294.
     
  269. Hagendorff A, Knebel F, Helfen A, Knierim J, Sinning C, Stöbe S, Fehske W, Ewen S (2020). Expert consensus document on the assessment of the severity of aortic valve stenosis by echocardiography to provide diagnostic conclusiveness by standardized verifiable documentation. Clin Res Cardiol, 109(3), 271-288.
     
  270. Mühleck F, Laufs U (2020). [Primary prevention of coronary heart disease : Evidence-based drug treatment]. Herz, 45(1), 39-49.
     
  271. Mühleck F, Laufs U (2020). Erratum zu: Primärprävention der koronaren Herzkrankheit : Evidenzbasierte medikamentöse Therapie. Herz, 45(2), 199-200.
     
  272. Bobenko A, Duvinage A, Mende M, Holzendorf V, Nolte K, Herrmann-Lingen C, Binder L, Düngen HD, Hasenfuss G, Pieske B, Wachter R, Edelmann F (2020). Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction. Int J Cardiol Heart Vasc, 28(), 100525.
     
  273. Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Ziegler PD, Kaplon RE, Sherfesee L, Wachter R (2020). Rhythm monitoring strategies in patients at high risk for atrial fibrillation and stroke: A comparative analysis from the REVEAL AF study. Am Heart J, 219(), 128-136.
     
  274. Schulz M, Griese-Mammen N, Schumacher PM, Anker SD, Koehler F, Ruckes C, Rettig-Ewen V, Wachter R, Trenk D, Böhm M, Laufs U (2020). The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial. ESC Heart Fail, 7, 3310-9.
     
  275. Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan SR, Paschen A, Herter T, Schuster S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T (2020). Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat Immunol, 21(1), 30-41.
     
  276. Fikenzer S, Uhe T, Lavall D, Rudolph U, Falz R, Busse M, Hepp P, Laufs U (2020). Response to the letter to the editor by Kampert et al. entitled "Impact of wearing a facial covering on aerobic exercise capacity in the COVID-19 Era: is it more than a feeling?" Clin Res Cardiol, 109(12), 1597.
     
  277. Banach M, Duell PB, Gotto AM Jr, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Flaim J, Ye Z, Catapano AL (2020). Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. JAMA Cardiol, 5, 1-12.
     
  278. Rogacev KS, Laufs U (2020). [Lipid management 2020 - medical therapy and lipid apheresis in context]. Dtsch Med Wochenschr, 145(7), 464-469.
     
  279. Schuster-Gaul S, Geisler LJ, McGeough MD, Johnson CD, Zagorska A, Li L, Wree A, Barry V, Mikaelian I, Jih LJ, Papouchado BG, Budas G, Hoffman HM, Feldstein AE (2020). ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model. JCI Insight, 5(2), e123294.
     
  280. Glaser SF, Heumüller AW, Tombor L, Hofmann P, Muhly-Reinholz M, Fischer A, Günther S, Kokot KE, Hassel D, Kumar S, Jo H, Boon RA, Abplanalp W, John D, Boeckel JN, Dimmeler S (2020). The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition. Proc Natl Acad Sci U S A, 117(8), 4180-4187.
     
  281. Stöbe S, Hagendorff A, Gutberlet M, Tayal B (2020). Myocardial Work: A Modern Tool to Detect Possible Compensation Mechanism of Deformation in Acute Myocarditis with Preserved Left Ventricular Function. J Cardiovasc Echogr, 30(4), 206-210.
     
  282. Herrmann-Lingen C, Albus C, de Zwaan M, Geiser F, Heinemann K, Hellmich M, Michal M, Sadlonova M, Tostmann R, Wachter R, Herbeck Belnap B (2020). Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial. BMC Cardiovasc Disord, 20(1), 520.
     
  283. Tsugu T, Postolache A, Dulgheru R, Sugimoto T, Tridetti J, Nguyen Trung ML, Piette C, Moonen M, Manganaro R, Ilardi F, Chitroceanu AM, Sperlongano S, Go YY, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Rosca M, Calin A, Magne J, Cosyns B, Galli E, Donal E, Santoro C, Galderisi M, Badano LP, Lang RM, Lancellotti P (2020). Echocardiographic reference ranges for normal left ventricular layer-specific strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 21(8), 896-905.
     
  284. Tsugu T, Postolache A, Dulgheru R, Sugimoto T, Tridetti J, Nguyen Trung ML, Piette C, Moonen M, Manganaro R, Ilardi F, Chitroceanu AM, Sperlongano S, Go YY, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Rosca M, Calin A, Magne J, Cosyns B, Galli E, Donal E, Santoro C, Galderisi M, Badano LP, Lang RM, Lancellotti P (2020). Echocardiographic reference ranges for normal left ventricular layer-specific strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 21(8), 896-905.
     
  285. Mahfoud F, Kieble M, Enners S, Werning J, Laufs U, Millenaar D, Böhm M, Kintscher U, Schulz M (2020). "Dear Doctor" Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription. Dtsch Arztebl Int, 117(41), 687-688.
     
  286. Lässing J, Falz R, Pökel C, Fikenzer S, Laufs U, Schulze A, Hölldobler N, Rüdrich P, Busse M (2020). Effects of surgical face masks on cardiopulmonary parameters during steady state exercise. Sci Rep, 10(1), 22363.
     
  287. Al Ali R, Vukadinovi? D, Maziak W, Katmeh L, Schwarz V, Mahfoud F, Laufs U, Böhm M (2020). Cardiovascular effects of waterpipe smoking: a systematic review and meta-analysis. Rev Cardiovasc Med, 21(3), 453-468.
     
  288. Bays HE, Banach M, Catapano AL, Duell PB, Gotto AM Jr, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Bloedon LT, Sasiela WJ, Ye Z, Ballantyne CM (2020). Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials. J Clin Lipidol, 14(5), 649-659.
     
  289. Schulz M, Griese-Mammen N, Schumacher PM, Strauch D, Freudewald L, Said A, Tsuyuki RT, Laufs U, Kintscher U, Böhm M, Mahfoud F (2020). Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. J Clin Hypertens (Greenwich), 22(10), 1807-1816.
     
  290. Shafieesabet A, Scherbakov N, Ebner N, Sandek A, Lokau S, von Haehling S, Anker SD, Lainscak M, Laufs U, Doehner W (2020). Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls. Nutr Metab Cardiovasc Dis, 30(11), 1961-1966.
     
  291. Schlunk F, Fischer P, Princen HMG, Rex A, Prinz V, Foddis M, Lütjohann D, Laufs U, Endres M (2020). Effects of Inhibition or Deletion of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) on Intracerebral Hemorrhage Volumes in Mice. Stroke, 51(11), 297-298.
     
  292. Barter PJ, Yamashita S, Laufs U, Ruiz AJ, Sy R, Fang MDG, Folco E, Libby P, Matsuzawa Y, Santos RD (2020). Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey. Lipids Health Dis, 19(1), 131.
     
  293. Hagman M, Werner C, Kamp K, Fristrup B, Hornstrup T, Meyer T, Böhm M, Laufs U, Krustrup P (2020). Reduced telomere shortening in lifelong trained male football players compared to age-matched inactive controls. Prog Cardiovasc Dis, 63(6), 738-749.
     
  294. Wintrich J, Kindermann I, Ukena C, Selejan S, Werner C, Maack C, Laufs U, Tschöpe C, Anker SD, Lam CSP, Voors AA, Böhm M (2020). Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future. Clin Res Cardiol, 109(9), 1079-1098.
     
  295. Grammer TB, Dressel A, Gergei I, Kleber ME, Laufs U, Scharnagl H, Nixdorff U, Klotsche J, Pieper L, Pittrow D, Silber S, Wittchen HU, März W (2020). Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study. Sci Rep, 10(1), 5945.
     
  296. Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN (2020). Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 41(24), 2313-2330.
     
  297. Ray KK, Laufs U, Cosentino F, Lobo MD, Landmesser U (2020). The year in cardiology: cardiovascular prevention. Eur Heart J, 41(11), 1157-1163.
     
  298. Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan SR, Paschen A, Herter T, Schuster S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T (2020). Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat Immunol, 21(1), 30-41.
     
  299. Tinahones FJ, Laufs U, Cariou B, Louie MJ, Yang J, Thompson D, Leiter LA (2020). Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials. Diabetes Metab, 46(4), 280-287.
     
  300. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O (2020). 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 41(1), 111-188.
     
  301. Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C (2020). Higher galectin-3 levels are independently associated with lower anxiety in patients with risk factors for heart failure. Biopsychosoc Med, 14(), 24.
     
  302. Gröschel S, Lange B, Wasser K, Hahn M, Wachter R, Gröschel K, Uphaus T (2020). Software-based analysis of 1-hour Holter ECG to select for prolonged ECG monitoring after stroke. Ann Clin Transl Neurol, 7(10), 1779-1787.
     
  303. Pascual-Figal D, Wachter R, Senni M, Bao W, Noè A, Schwende H, Butylin D, Prescott MF (2020). NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study. JACC Heart Fail, 8(10), 822-833.
     
  304. Bobenko A, Duvinage A, Mende M, Holzendorf V, Nolte K, Herrmann-Lingen C, Binder L, Düngen HD, Hasenfuss G, Pieske B, Wachter R, Edelmann F (2020). Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction. Int J Cardiol Heart Vasc, 28(), 100525.
     
  305. Gröschel S, Lange B, Grond M, Jauss M, Kirchhof P, Rostock T, Wachter R, Gröschel K, Uphaus T (2020). Automatic Holter electrocardiogram analysis in ischaemic stroke patients to detect paroxysmal atrial fibrillation: ready to replace physicians? Eur J Neurol, 27(7), 1272-1278.
     
  306. Hashemi D, Blum M, Mende M, Störk S, Angermann CE, Pankuweit S, Tahirovic E, Wachter R, Pieske B, Edelmann F, Düngen HD (2020). Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany. ESC Heart Fail, 7(3), 942-952.
     
  307. Hashemi D, Dettmann L, Trippel TD, Holzendorf V, Petutschnigg J, Wachter R, Hasenfuß G, Pieske B, Zapf A, Edelmann F (2020). Economic impact of heart failure with preserved ejection fraction: insights from the ALDO-DHF trial. ESC Heart Fail, 7(3), 786-793.
     
  308. Petutschnigg J, Ferreira JP, Holzendorf V, Trippel TD, Hashemi D, Wachter R, Herrmann-Lingen C, Hasenfuß G, Zannad F, Pieske B, Edelmann F (2020). Body fat phenotypes and treatment response to spironolactone in ambulatory patients with heart failure and preserved ejection fraction: a post-hoc analysis of the Aldo-DHF trial. Eur J Heart Fail, 22(3), 559-561.
     
  309. Senni M, Wachter R, Witte KK, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Chakrabarti A, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D (2020). Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study. Eur J Heart Fail, 22(2), 303-312.
     
  310. Ebner M, Rogge NIJ, Parwani AS, Sentler C, Lerchbaumer MH, Pieske B, Konstantinides SV, Hasenfuß G, Wachter R, Lankeit M (2020). Atrial fibrillation is frequent but does not affect risk stratification in pulmonary embolism. J Intern Med, 287(1), 100-113.
     
  311. Bosselmann L, Fangauf SV, Herbeck Belnap B, Chavanon ML, Nagel J, Neitzel C, Schertz A, Hummers E, Wachter R, Herrmann-Lingen C (2020). Blended collaborative care in the secondary prevention of coronary heart disease improves risk factor control: Results of a randomised feasibility study. Eur J Cardiovasc Nurs, 19(2), 134-141.
     
  312. Wallbach M, Born E, Kämpfer D, Lüders S, Müller GA, Wachter R, Koziolek MJ (2020). Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system. Clin Res Cardiol, 109(4), 513-522.
     
  313. Waltenberger J, Brachmann J, van der Heyden J, Richardt G, Fröbert O, Seige M, Friedrich G, Erglis A, Winkens M, Hegeler-Molkewehrum C, Neef M, Hoffmann S (2020). Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting Stent. Cardiovasc Revasc Med, 21(1), 63-69.
     
  314. Polito MV, Hagendorff A, Citro R, Prota C, Silverio A, De Angelis E, Klingel K, Metze M, Stöbe S, Hoffmann KT, Sabri O, Piscione F, Galasso G (2020). Loeffler's Endocarditis: An Integrated Multimodality Approach. J Am Soc Echocardiogr, 33(12), 1427-1441.
     
  315. Pfrepper C, Metze M, Siegemund A, Klöter T, Siegemund T, Petros S (2020). Direct oral anticoagulant plasma levels and thrombin generation on ST Genesia system. Res Pract Thromb Haemost, 4(4), 619-627.
     
  316. Zehendner CM, Valasarajan C, Werner A, Boeckel JN, Bischoff FC, John D, Weirick T, Glaser SF, Rossbach O, Jaé N, Demolli S, Khassafi F, Yuan K, de Jesus Perez VA, Michalik KM, Chen W, Seeger W, Guenther A, Wasnick RM, Uchida S, Zeiher AM, Dimmeler S, Pullamsetti SS (2020). Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFR?. Am J Respir Crit Care Med, 202(10), 1445-1457.
     
  317. Glaser SF, Heumüller AW, Tombor L, Hofmann P, Muhly-Reinholz M, Fischer A, Günther S, Kokot KE, Hassel D, Kumar S, Jo H, Boon RA, Abplanalp W, John D, Boeckel JN, Dimmeler S (2020). The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition. Proc Natl Acad Sci U S A, 117(8), 4180-4187.
     
  318. Kosiuk J, Langenhan K, Stegmann C, Uhe T, Dagres N, Dinov B, Kircher S, Richter S, Sommer P, Bertagnolli L, Bollmann A, Hindricks G (2020). Effect of remote ischemic preconditioning on electrophysiological parameters in nonvalvular paroxysmal atrial fibrillation: The RIPPAF Randomized Clinical Trial. Heart Rhythm, 17(1), 3-9.
     
  319. Zehendner CM, Valasarajan C, Werner A, Boeckel JN, Bischoff FC, John D, Weirick T, Glaser SF, Rossbach O, Jaé N, Demolli S, Khassafi F, Yuan K, de Jesus Perez VA, Michalik KM, Chen W, Seeger W, Guenther A, Wasnick RM, Uchida S, Zeiher AM, Dimmeler S, Pullamsetti SS (2020). Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFR?. Am J Respir Crit Care Med, 202(10), 1445-1457.
     
  320. Leitsmann C, Uhlig A, Popeneciu IV, Boos M, Ahyai SA, Schmid M, Wachter R, Trojan L, Friedrich M (2020). The Silent Operation Theatre Optimisation System (SOTOS©) to reduce noise pollution during da Vinci robot-assisted laparoscopic radical prostatectomy. J Robot Surg, (), 1-9.
     
  321. Banach M, Duell PB, Gotto AM Jr, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Flaim J, Ye Z, Catapano AL (2020). Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. JAMA Cardiol, 5, 1-12.
     
  322. Task Force Members (2020). Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. Atherosclerosis, 294(), 80-82.
     
  323. Task Force Members (2020). Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. Atherosclerosis, 292(), 160-162.
     
  324. Ballantyne CM, Laufs U, Ray KK, Leiter LA, Bays HE, Goldberg AC, Stroes ES, MacDougall D, Zhao X, Catapano AL (2020). Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. Eur J Prev Cardiol, 27(6), 593-603.
     
  325. Polito MV, Hagendorff A, Citro R, Prota C, Silverio A, De Angelis E, Klingel K, Metze M, Stöbe S, Hoffmann KT, Sabri O, Piscione F, Galasso G (2020). Loeffler's Endocarditis: An Integrated Multimodality Approach. J Am Soc Echocardiogr, 33(12), 1427-1441.
     
  326. Tayal B, Freeman P, Ericsson F, Kragholm KH, Andersen NH, Hagendorff A, Aaroe J, Sogaard P, Zaremba T (2020). Characterisation of patients with and without cardiac magnetic resonance imaging abnormalities presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA). Acta Cardiol, (), 1-9.
     
  327. Manganaro R, Marchetta S, Dulgheru R, Sugimoto T, Tsugu T, Ilardi F, Cicenia M, Ancion A, Postolache A, Martinez C, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Rosca M, Calin A, Moonen M, Magne J, Cosyns B, Galli E, Donal E, Carerj S, Zito C, Santoro C, Galderisi M, Badano LP, Lang RM, Lancellotti P (2020). Correlation between non-invasive myocardial work indices and main parameters of systolic and diastolic function: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 21(5), 533-541.
     
  328. Amorim PA, Diab M, Walther M, Färber G, Hagendorff A, Bonow RO, Doenst T (2020). Limitations in the Assessment of Prosthesis-Patient Mismatch. Thorac Cardiovasc Surg, 68(7), 550-556.
     


    329. 2019


  329. Schuster S, Rubil S, Endres M, Princen HMG, Boeckel JN, Winter K, Werner C, Laufs U (2019). Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice. Sci Rep, 9), 11079-.
     
  330. Boeckel JN, Perret MF, Glaser SF, Seeger T, Heumuller AW, Chen W, John D, Kokot KE, Katus HA, Haas J, Lackner MK, Kayvanpour E, Grabe N, Dieterich C, von Haehling S, Ebner N, Hunecke S, Leuschner F, Fichtlscherer S, Meder B, Zeiher AM, Dimmeler S, Keller T (2019). Identification and regulation of the long non-coding RNA Heat2 in heart failure. J Mol Cell Cardiol, 126, 13-22.
     
  331. Polito MV, Stoebe S, Galasso G, De Rosa R, Citro R, Piscione F, Laufs U, Hagendorff A (2019). Analysis of Regional Right Ventricular Function by Tissue Doppler Imaging in Patients with Aortic Stenosis. J Cardiovasc Echogr, 29, 111-118.
     
  332. Hagendorff A, Doenst T, Falk V (2019). Echocardiographic assessment of functional mitral regurgitation: opening Pandora's box? ESC Heart Fail, 6, 678-685.
     
  333. Spies C, Metze M, Stobe S, Hagendorff A (2019). [Echocardiographic emergency diagnostics]. Herz, 44, 267-286.
     
  334. Farese GE, Tayal B, Stobe S, Laufs U, Hagendorff A (2019). Regional Disparities of Left Atrial Appendage Wall Contraction in Patients With Sinus Rhythm and Atrial Fibrillation. J Am Soc Echocardiogr, 32, 755-762.
     
  335. Hagendorff A, Evangelista A, Fehske W, Schafers HJ (2019). Improvement in the Assessment of Aortic Valve and Aortic Aneurysm Repair by 3-Dimensional Echocardiography. JACC Cardiovasc Imaging, 12, 2225-2244.
     
  336. Stobe S, Metze M, Spies C, Hagendorff A (2019). [Transesophageal echocardiography in emergency and intensive care medicine : Indication and implementation]. Med Klin Intensivmed Notfmed, 114, 490-498.
     
  337. Lenk K, Hagendorff A, Laufs U, Dahnert I (2019). Retrieval of an embolised occluder with an alligator forceps during staged paravalvular leakage closure. Clin Res Cardiol, 108, 824-827.
     
  338. Spies C, Laufs U, Hagendorff A, Metze M (2019). Case report: panic attacks as symptom of aortic regurgitation and aneurysm. Clin Res Cardiol, 108, 448-451.
     
  339. Pfeiffer D, Tebbenjohanns J, Klein N, Metze M, Neef M (2019). [History of catheter ablation]. Herzschrittmacherther Elektrophysiol, 30, 325-329.
     
  340. Neef M, Berndt K, Spies C, Laufs U, Metze M (2019). [Cardiac arrhythmias in patients with chronic autoimmune diseases]. Herzschrittmacherther Elektrophysiol, 30, 240-244.
     
  341. Lavall D, Jacobs N, Mahfoud F, Kolkhof P, Bohm M, Laufs U (2019). The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling. Biochem Pharmacol, 168, 173-183.
     
  342. Bae YJ, Kratzsch J, Zeidler R, Fikenzer S, Werner C, Herm J, Jungehulsing GJ, Endres M, Haeusler KG, Thiery J, Laufs U (2019). Unraveling the steroid hormone response in male marathon runners: Correlation of running time with aldosterone and progesterone. J Steroid Biochem Mol Biol, 195, 105473-.
     
  343. Fikenzer S, Fikenzer K, Bauer Y, Kuehl M, Hindricks G, Bollmann A, Bode K (2019). Pain During "Noncomplex" Electrophysiological Studies and Cardiac Rhythm Device Surgery. J Cardiovasc Nurs, 34, 517-527.
     
  344. Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, Schumacher PM, Trenk D, Bohm M, Laufs U (2019). Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail, 21, 1012-1021.
     
  345. Rudolph U, Laufs U (2019). [Cardiologic Check-ups]. Dtsch Med Wochenschr, 144, 1192-1201.
     
  346. Uphaus T, Bittner S, Groschel S, Steffen F, Muthuraman M, Wasser K, Weber-Kruger M, Zipp F, Wachter R, Groschel K (2019). NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke. Stroke, 50, 3077-3084.
     
  347. Haarmann H, Koch J, Bonsch N, Mende M, Werhahn SM, Luers C, Stahrenberg R, Edelmann F, Holzendorf V, von Haehling S, Pieske B, Andreas S, Luthje L, Wachter R (2019). Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort. Respir Med, 154, 127-132.
     
  348. Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bohmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, A L Buraiki J, Gniot J, Mozheiko M, Lelonek M, Noe A, Schwende H, Bao W, Butylin D, Pascual-Figal D (2019). Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. Eur J Heart Fail, 21, 998-1007.
     
  349. Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, Schumacher PM, Trenk D, Bohm M, Laufs U (2019). Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail, 21, 1012-1021.
     
  350. Wasser K, Weber-Kruger M, Jurries F, Liman J, Hamann GF, Kermer P, Uphaus T, Protsenko E, Seegers J, Mende M, Groschel K, Wachter R (2019). The cardiac diagnostic work-up in stroke patients-A subanalysis of the Find-AFRANDOMISED trial. PLoS One, 14, 0216530-.
     
  351. Stegmann T, Wachter R, Schabitz WR (2019). [Embolic stroke of undetermined source (ESUS) : How much monitoring is necessary?] Herz, 44, 289-295.
     
  352. Wachter R, Fonseca AF, Balas B, Kap E, Engelhard J, Schlienger R, Klebs S, Wirta SB, Kostev K (2019). Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany. Eur J Heart Fail, 21, 588-597.
     
  353. Uphaus T, Weber-Kruger M, Grond M, Toenges G, Jahn-Eimermacher A, Jauss M, Kirchhof P, Wachter R, Groschel K (2019). Development and validation of a score to detect paroxysmal atrial fibrillation after stroke. Neurology, 92, e115-e124.
     
  354. Katzmann JL, Tunnemann-Tarr A, Laufs U (2019). [European dyslipidemia guidelines 2019 : What is new?] Herz, 44, 688-695.
     
  355. Katzmann JL, Laufs U (2019). New Insights in the Control of Low-Density Lipoprotein Cholesterol to Prevent Cardiovascular Disease. Curr Cardiol Rep, 21, 69-.
     
  356. Werner CM, Hecksteden A, Morsch A, Bohm M, Meyer T, Laufs U (2019). Response to: Jiménez-Pavon et al. and Patanè. Eur Heart J, 40, 3201-.
     
  357. Metze M, Davierwala PM, Andreas H, Klingel K, Laufs U, Kloter T (2019). Progression of left ventricular thrombus in Loeffler's endocarditis without eosinophilia-case report and review of the literature. Clin Res Cardiol, 108, 1163-1170.
     
  358. Laufs U, Banach M, Mancini GBJ, Gaudet D, Bloedon LT, Sterling LR, Kelly S, Stroes ESG (2019). Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. J Am Heart Assoc, 8, e011662-.
     
  359. Werner CM, Hecksteden A, Morsch A, Zundler J, Wegmann M, Kratzsch J, Thiery J, Hohl M, Bittenbring JT, Neumann F, Bohm M, Meyer T, Laufs U (2019). Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study. Eur Heart J, 40, 34-46.
     
  360. Laufs U, Dent R, Kostenuik PJ, Toth PP, Catapano AL, Chapman MJ (2019). Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine. Eur Heart J, 40, 2825-2830.
     
  361. Katzmann JL, Laufs U (2019). Why doesn't high cholesterol hurt? Aging (Albany NY), 11, 10788-10790.
     
  362. Katzmann L, Ference BA, Laufs U (2019). Prinzip der mendelschen Randomisierung und Anwendung in der kardiovaskulären Medizin Der Kardiologe, 13, 146-152.
     
  363. Katzmann JL, Laufs U (2019). Lipoprotein(a) in der Prädiktion kardiovaskulärer Ereignisse Deutsche Medizinische Wochenschrift, 144, 299-302.
     
  364. Kosiuk J, Uhe T, Stegmann C, Ueberham L, Bertagnolli L, Dagres N, Dinov B, Mussigbrodt A, Richter S, Paetsch I, Jahnke C, Hilbert S, Sommer P, Hindricks G, Bollmann A (2019). Morphological determinators of platelet activation status in patients with atrial fibrillation. Int J Cardiol, 279, 90-95.
     
  365. Metze M, Ussat M, Stöbe S (2019). Notfallmedizinische Untersuchung Schritt für Schritt Notfallmedizin up2date , 14, 1-17.
     
  366. Metze M, Ussat M, Stöbe S (2019). Notfallmedizinische Untersuchung bei bewusstlosen Patienten Notf.med. up2date, 14, 127-132.
     
  367. Bluher M, Laufs U (2019). New concepts for body shape-related cardiovascular risk: role of fat distribution and adipose tissue function. Eur Heart J, 40, 2856-2858.
     
  368. Polito MV, Stoebe S, Galasso G, De Rosa R, Citro R, Piscione F, Laufs U, Hagendorff A (2019). Analysis of Regional Right Ventricular Function by Tissue Doppler Imaging in Patients with Aortic Stenosis. J Cardiovasc Echogr, 29(3), 111-118.
     
  369. Farese GE, Tayal B, Stöbe S, Laufs U, Hagendorff A (2019). Regional Disparities of Left Atrial Appendage Wall Contraction in Patients With Sinus Rhythm and Atrial Fibrillation. J Am Soc Echocardiogr, 32(6), 755-762.
     
  370. Kavalerchyk V, Stobe S, Hagendorff A, Augustyniak J, Staudt A (2019). [Right Atrial Thrombus Formation as Complications in the Presence of Hemodialysis Catheter and Central Venous Catheter]. Dtsch Med Wochenschr, 144, 1349-1353.
     
  371. Kornej J, Zeynalova S, Buttner P, Burkhardt R, Bae YJ, Willenberg A, Baber R, Thaler A, Hindricks G, Loeffler M, Hagendorff A, Thiele H, Thiery J (2019). Differentiation of atrial fibrillation progression phenotypes using Troponin T. Int J Cardiol, 297, 61-65.
     
  372. Kornej J, Zeynalova S, Thiery J, Burkhardt R, Baber R, Engel C, Hagendorff A, Loeffler M, Husser D (2019). Association between echocardiographic parameters and biomarkers in probands with atrial fibrillation and different PR interval lengths: Insight from the epidemiologic LIFE Adult Study. PLoS One, 14, 0212627-0212627.
     
  373. Manganaro R, Marchetta S, Dulgheru R, Ilardi F, Sugimoto T, Robinet S, Cimino S, Go YY, Bernard A, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez-Fernandez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Rosca M, Calin A, Moonen M, Magne J, Cosyns B, Galli E, Donal E, Carerj S, Zito C, Santoro C, Galderisi M, Badano LP, Lang RM, Oury C, Lancellotti P (2019). Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 20, 582-590.
     
  374. Desch S, Freund A, Graf T, Fichtlscherer S, Haake H, Preusch M, Hammer F, Akin I, Christ M, Liebetrau C, Skurk C, Steiner S, Voigt I, Schmitz R, Mudra H, Ledwoch J, Menck N, Horstkotte J, Pels K, Lahmann AL, Otto S, Lenk K, Ohlow MA, Hassager C, Nordbeck P, Zeymer U, Jobs A, de Waha-Thiele S, Olbrich D, Konig I, Klinge K, Thiele H (2019). Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation: Design and rationale of the TOMAHAWK trial. Am Heart J, 209, 20-28.
     
  375. Ondruschka B, Babian C, Neef M, Zwirner J, Schwarz M (2019). Entomological and Cardiologic Evidence of Time Since Death in Short Postmortem Intervals. J Forensic Sci, 64, 1563-1567.
     
  376. Vukadinovic D, Vukadinovic AN, Lavall D, Laufs U, Wagenpfeil S, Bohm M (2019). Rate of Cough During Treatment With Angiotensin-Converting Enzyme Inhibitors: A Meta-Analysis of Randomized Placebo-Controlled Trials. Clin Pharmacol Ther, 105, 652-660.
     
  377. Falz R, Fikenzer S, Holzer R, Laufs U, Fikenzer K, Busse M (2019). Acute cardiopulmonary responses to strength training, high-intensity interval training and moderate-intensity continuous training. Eur J Appl Physiol, 119, 1513-1523.
     
  378. Falz R, Fikenzer S, Hoppe S, Busse M (2019). Normal Values of Hemoglobin Mass and Blood Volume in Young, Active Women and Men. Int J Sports Med, 40, 236-244.
     
  379. Hommel J, Ohmichen S, Rudolph UM, Hauser T, Schulz H (2019). Effects of six-week sprint interval or endurance training on calculated power in maximal lactate steady state. Biol Sport, 36, 47-54.
     
  380. Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J, Brandes A, Bustamante A, Casadei B, Crijns HJGM, Doehner W, Engstrom G, Fauchier L, Friberg L, Gladstone DJ, Glotzer TV, Goto S, Hankey GJ, Harbison JA, Hobbs FDR, Johnson LSB, Kamel H, Kirchhof P, Korompoki E, Krieger DW, Lip GYH, Lochen ML, Mairesse GH, Montaner J, Neubeck L, Ntaios G, Piccini JP, Potpara TS, Quinn TJ, Reiffel JA, Ribeiro ALP, Rienstra M, Rosenqvist M, Sakis T, Sinner MF, Svendsen JH, Van Gelder IC, Wacht (2019). Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. Circulation, 140, 1834-1850.
     
  381. Fangauf SV, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Sollner W, Wachter R, Weber CS, Herrmann-Lingen C (2019). Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression. J Psychosom Res, 123, 109728-.
     
  382. Diekmann S, Horster L, Evers S, Hiligsmann M, Gelbrich G, Groschel K, Wachter R, Hamann GF, Kermer P, Liman J, Weber-Kruger M, Wasem J, Neumann A (2019). Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients. Curr Med Res Opin, 35, 1859-1866.
     
  383. Verma A, Wachter R, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Kaplon RE, Ziegler PD, Sherfesee L, Reiffel JA (2019). Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study). Am J Cardiol, 124, 864-870.
     
  384. Tsivgoulis G, Katsanos AH, Grory BM, Kohrmann M, Ricci BA, Tsioufis K, Cutting S, Krogias C, Schellinger PD, Campello AR, Cuadrado-Godia E, Gladstone DJ, Sanna T, Wachter R, Furie K, Alexandrov AV, Yaghi S (2019). Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke, 50, 2175-2180.
     
  385. Bahls M, Friedrich N, Pietzner M, Wachter R, Budde K, Hasenfuss G, Nauck M, Pressler A, Felix SB, Edelmann F, Halle M, Dorr M (2019). Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction. J Clin Med, 8, 591.
     
  386. Schertz A, Herbeck Belnap B, Chavanon ML, Edelmann F, Wachter R, Herrmann-Lingen C (2019). Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study. ESC Heart Fail, 6, 658-666.
     
  387. Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Dungen HD, Angermann CE, Hasenfuss G, Pieske B, Wachter R, Edelmann F (2019). Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction. ESC Heart Fail, 6, 262-270.
     
  388. Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C (2019). Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study. Psychoneuroendocrinology, 101, 272-277.
     
  389. Authors/Task Force Members (2019). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, 140-205.
     
  390. Bluher M, Laufs U (2019). New concepts for body shape-related cardiovascular risk: role of fat distribution and adipose tissue function. Eur Heart J, 40, 2856-2858.
     
  391. Dressel A, Schmidt B, Schmidt N, Laufs U, Fath F, Chapman MJ, Grammer TB, Marz W (2019). Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohort. Vascul Pharmacol, 120, 106566-.
     
  392. Boujon V, Uhlemann R, Wegner S, Wright MB, Laufs U, Endres M, Kronenberg G, Gertz K (2019). Dual PPAR?/? agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice. J Mol Med (Berl), 97, 1127-1138.
     
  393. Weingartner O, Lutjohann D, Meyer S, Fuhrmann A, Cremers B, Seiler-Mussler S, Schott HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada A, Laufs U, Schulze PC, Scheller B, Fliser D, Bohm M, Sijbrands E, Heine GH (2019). Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study. Clin Res Cardiol, 108, 1381-1385.
     
  394. Hollstein T, Vogt A, Grenkowitz T, Stojakovic T, Marz W, Laufs U, Bolukbasi B, Steinhagen-Thiessen E, Scharnagl H, Kassner U (2019). Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study. Vascul Pharmacol, 116, 8-15.
     
  395. Grammer TB, Dressel A, Gergei I, Kleber ME, Laufs U, Scharnagl H, Nixdorff U, Klotsche J, Pieper L, Pittrow D, Silber S, Wittchen HU, Marz W (2019). Cardiovascular risk algorithms in primary care: Results from the DETECT study. Sci Rep, 9, 1101-.
     
  396. Ihle P, Krueger K, Schubert I, Griese-Mammen N, Parrau N, Laufs U, Schulz M (2019). Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure. Clin Pharmacol Ther, 106, 211-218.
     
  397. Ference BA, Kastelein JJP, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, Laufs U, Oliver-Williams C, Wood AM, Butterworth AS, Di Angelantonio E, Danesh J, Nicholls SJ, Bhatt DL, Sabatine MS, Catapano AL (2019). Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease. JAMA, 321, 364-373.
     
  398. Slawik J, Adrian L, Hohl M, Lothschutz S, Laufs U, Bohm M (2019). Irregular pacing of ventricular cardiomyocytes induces pro-fibrotic signalling involving paracrine effects of transforming growth factor beta and connective tissue growth factor. Eur J Heart Fail, 21, 482-491.
     
  399. Hohneck AL, Fries P, Stroder J, Schneider G, Wagenpfeil S, Schirmer SH, Bohm M, Laufs U, Custodis F (2019). Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease. J Hypertens, 37, 1023-1031.
     
  400. Reiner Z, Laufs U, Cosentino F, Landmesser U (2019). The year in cardiology 2018: prevention. Eur Heart J, 40(4), 336-344.
     
  401. Silbernagel G, Steiner LK, Hollstein T, Fauler G, Scharnagl H, Stojakovic T, Schumann F, Bolukbasi B, Marz W, Steinhagen-Thiessen E, Laufs U, Kassner U (2019). The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption. J Lipid Res, 60, 161-167.
     
  402. Kosiuk J, Uhe T, Stegmann C, Ueberham L, Bertagnolli L, Dagres N, Dinov B, Mussigbrodt A, Richter S, Paetsch I, Jahnke C, Hilbert S, Sommer P, Hindricks G, Bollmann A (2019). Morphological determinators of platelet activation status in patients with atrial fibrillation. Int J Cardiol, 279, 90-95.
     
  403. Pfrepper C, Deters S, Metze M, Siegemund R, Gockel I, Petros S (2019). Metamizole inhibits arachidonic acid-induced platelet aggregation after surgery and impairs the effect of aspirin in hospitalized patients. Eur J Clin Pharmacol, 75, 777-784.
     
  404. Pfrepper C, Poenisch W, Pierer M, Metze M, Kaiser T, Petros S (2019). Inhibitor eradication in refractory acquired hemophilia with lenalidomide. Ann Hematol, 98, 1533-1535.
     
  405. Kavalerchyk V, Stöbe S, Hagendorff A, Augustyniak J, Staudt A (2019). [Right Atrial Thrombus Formation as Complications in the Presence of Hemodialysis Catheter and Central Venous Catheter]. Dtsch Med Wochenschr, 144(19), 1349-1353.
     
  406. Kavalerchyk V, Stöbe S, Hagendorff A, Augustyniak J, Staudt A (2019). [Right Atrial Thrombus Formation as Complications in the Presence of Hemodialysis Catheter and Central Venous Catheter]. Dtsch Med Wochenschr, 144(19), 1349-1353.
     
  407. Kavalerchyk V, Stöbe S, Hagendorff A, Augustyniak J, Staudt A (2019). [Right Atrial Thrombus Formation as Complications in the Presence of Hemodialysis Catheter and Central Venous Catheter]. Dtsch Med Wochenschr, 144(19), 1349-1353.
     


    408. 2018


  408. Katzmann JL, Mahfoud F, Bohm M, Schulz M, Laufs U (2018). Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk. Patient Prefer Adherence, 13, 9-19.
     
  409. Schuster S, Cabrera D, Arrese M, Feldstein AE (2018). Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol, 15(6), 349-364.
     
  410. Ramsden CE, Hennebelle M, Schuster S, Keyes GS, Johnson CD, Kirpich IA, Dahlen JE, Horowitz MS, Zamora D, Feldstein AE, McClain CJ, Muhlhausler BS, Makrides M, Gibson RA, Taha AY (2018). Effects of diets enriched in linoleic acid and its peroxidation products on brain fatty acids, oxylipins, and aldehydes in mice. Biochim Biophys Acta Mol Cell Biol Lipids, 1863(10), 1206-1213.
     
  411. Schuster S, Johnson CD, Hennebelle M, Holtmann T, Taha AY, Kirpich IA, Eguchi A, Ramsden CE, Papouchado BG, McClain CJ, Feldstein AE (2018). Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice. J Lipid Res, 59(9), 1597-1609.
     
  412. Heumuller AW, Boeckel JN (2018). Characterization and Validation of Circular RNA and Their Host Gene mRNA Expression Using PCR. Methods Mol Biol, 1724, 57-67.
     
  413. Herrmann-Lingen C, Meyer T, Bosbach A, Chavanon ML, Hassoun L, Edelmann F, Wachter R (2018). Cross-Sectional and Longitudinal Associations of Systolic Blood Pressure With Quality of Life and Depressive Mood in Older Adults With Cardiovascular Risk Factors: Results From the Observational DIAST-CHF Study. Psychosom Med, 80(5), 468-474.
     
  414. Wachter R, Groschel K (2018). [Acute treatment and secondary prophylaxis of ischemic stroke : An excellent example for personalized medicine]. Internist (Berl), 59(3), 241-251.
     
  415. Wachter R (2018). [Atrial fibrillation as a comorbidity of heart failure]. Internist (Berl), 59(5), 415-419.
     
  416. Wallbach M, Koziolek MJ, Wachter R (2018). [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure]. Internist (Berl), 59(10), 1011-1020.
     
  417. Pfrepper C, Peschka A, Weidhase L, Kaiser T, Petros S, Metze M (2018). Management of Dabigatran-associated bleeding in two elderly patients with acute renal failure. Ann Hematol, 97(12), 2519-2521.
     
  418. Hagendorff A, Stoebe S, Tayal B (2018). A systematic approach to 3D echocardiographic assessment of the aortic root. Glob Cardiol Sci Pract, 2018(2), 12-.
     
  419. Boeckel JN, Perret MF, Glaser SF, Seeger T, Heumuller AW, Chen W, John D, Kokot KE, Katus HA, Haas J, Lackner MK, Kayvanpour E, Grabe N, Dieterich C, von Haehling S, Ebner N, Hunecke S, Leuschner F, Fichtlscherer S, Meder B, Zeiher AM, Dimmeler S, Keller T (2018). Identification and regulation of the long non-coding RNA Heat2 in heart failure. J Mol Cell Cardiol, 126, 13-22.
     
  420. Eger N, Schoppe L, Schuster S, Laufs U, Boeckel JN (2018). Circular RNA Splicing. Adv Exp Med Biol, 1087, 41-52.
     
  421. Tschope C, Birner C, Bohm M, Bruder O, Frantz S, Luchner A, Maier L, Stork S, Kherad B, Laufs U (2018). Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG). Clin Res Cardiol, 107(1), 1-19.
     
  422. Schwarz V, Dusing P, Liman T, Werner C, Herm J, Bachelier K, Krull M, Brechtel L, Jungehulsing GJ, Haverkamp W, Bohm M, Endres M, Haeusler KG, Laufs U (2018). Marathon running increases circulating endothelial- and thrombocyte-derived microparticles. Eur J Prev Cardiol, 25(3), 317-324.
     
  423. Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U (2018). Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins. Clin Res Cardiol, 107(5), 380-388.
     
  424. Nordestgaard BG, Cosentino F, Landmesser U, Laufs U (2018). The year in cardiology 2017: prevention. Eur Heart J, 39(5), 345-353.
     
  425. Lavall D, Hagendorff A, Schirmer SH, Bohm M, Borger MA, Laufs U (2018). Mitral valve interventions in heart failure. ESC Heart Fail, 5(4), 552-561.
     
  426. Polito MV, Stoebe S, Leifels L, Stumpp P, Solty K, Galasso G, Piscione F, Laufs U, Klingel K, Hagendorff A (2018). Cardiac sarcoidosis: a challenging diagnosis. Clin Res Cardiol, 107, 980-986.
     
  427. Laufs U, Griese-Mammen N, Krueger K, Wachter A, Anker SD, Koehler F, Rettig-Ewen V, Botermann L, Strauch D, Trenk D, Bohm M, Schulz M (2018). PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study. Eur J Heart Fail, 20, 1350-1359.
     
  428. Katzmann J, Schurfeld C, Marz W, Laufs U (2018). Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia. J Clin Lipidol, 12(4), 868-871.
     
  429. Laufs U, Weingartner O (2018). Pathological phenotypes of LDL particles. Eur Heart J, 39(27), 2574-2576.
     
  430. Lavall D, Mehrer M, Schirmer SH, Reil JC, Wagenpfeil S, Bohm M, Laufs U (2018). Long-Term Hemodynamic Improvement after Transcatheter Mitral Valve Repair. J Am Soc Echocardiogr, 31(9), 1013-1020.
     
  431. Fikenzer K, Fikenzer S, Laufs U, Werner C (2018). Effects of endurance training on serum lipids. Vascul Pharmacol, 101, 9-20.
     
  432. Kazakov A, Hall RA, Werner C, Meier T, Trouvain A, Rodionycheva S, Nickel A, Lammert F, Maack C, Bohm M, Laufs U (2018). Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress. Basic Res Cardiol, 113(6), 42-.
     
  433. Fikenzer K, Fikenzer S, Laufs U, Werner C (2018). Effects of endurance training on serum lipids. Vascul Pharmacol, 101, 9-20.
     
  434. Nordestgaard BG, Cosentino F, Landmesser U, Laufs U (2018). The year in cardiology 2017: prevention. Eur Heart J, 39(5), 345-353.
     
  435. Pfeiffer D, Jurisch D, Monsuez JJ (2018). Cardiovascular Anniversaries in 2016. Eur Heart J, 39, 12-15.
     
  436. Wachter R, Viriato D, Klebs S, Grunow SS, Schindler M, Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B, Bruce Wirta S (2018). Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany. Postgrad Med, 130(3), 308-316.
     
  437. Pfeiffer D, Monsuez JJ, Klein N (2018). Cardiovascular Anniversaries in 2016. European Heart Journal, 39(1), 12-15.
     
  438. Lavall D, Scheller B, Werner C, Buob A, Mahfoud F (2018). Mitral valve pressure gradient after percutaneous mitral valve repair: every beat counts. ESC Heart Fail, 5(1), 193-196.
     
  439. Pfeiffer D, Monsuez JJ, Neef M (2018). Cardiovascular Anniversaries in 2018. Eur Heart J, 39(36), 3349-3352.
     
  440. Heumuller AW, Boeckel JN (2018). Characterization and Validation of Circular RNA and Their Host Gene mRNA Expression Using PCR. Methods Mol Biol, 1724, 57-67.
     
  441. Stoebe S, Metze M, Jurisch D, Tayal B, Solty K, Laufs U, Pfeiffer D, Hagendorff A (2018). Analysis of chronic aortic regurgitation by 2D and 3D echocardiography and cardiac MRI. Echo Res Pract, 5, 51-62.
     
  442. Pfeiffer D, Monsuez JJ, Klein N (2018). Cardiovascular Anniversaries in 2017. Eur Heart J, 39, 1327-1329.
     
  443. Pfeiffer D (2018). Cardiovascular Anniversaries in 2016. Eur Heart J, 39, 12-15.
     
  444. Galderisi M, Donal E, Magne J, Lo Iudice F, Agricola E, Sade LE, Cameli M, Schwammenthal E, Cardim N, Cosyns B, Hagendorff A, Neskovic AN, Zamorano JL, Lancellotti P, Habib G, Edvardsen T, Popescu BA (2018). Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. Eur Heart J Cardiovasc Imaging, 19(3), 245-252.
     
  445. Krueger K, Griese-Mammen N, Schubert I, Kieble M, Botermann L, Laufs U, Kloft C, Schulz M (2018). In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review. Heart Fail Rev, 23(1), 63-71.
     
  446. Doehner W, Ural D, Haeusler KG, Celutkiene J, Bestetti R, Cavusoglu Y, Pena-Duque MA, Glavas D, Iacoviello M, Laufs U, Alvear RM, Mbakwem A, Piepoli MF, Rosen SD, Tsivgoulis G, Vitale C, Yilmaz MB, An (2018). Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association. Eur J Heart Fail, 20(2), 199-215.
     
  447. Petersen J, Kazakov A, Bohm M, Schafers HJ, Laufs U, Abdul-Khaliq H (2018). Cardiopulmonary bypass reduces myocardial oxidative stress, inflammation and increases c-kit+CD45- cell population in newborns. J Transl Med, 16(1), 111-.
     
  448. Haeusler KG, Groschel K, Kohrmann M, Anker SD, Brachmann J, Bohm M, Diener HC, Doehner W, Endres M, Gerloff C, Huttner HB, Kaps M, Kirchhof P, Nabavi DG, Nolte CH, Pfeilschifter W, Pieske B, Poli S, S (2018). Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clin Res Cardiol, 107(10), 871-880.
     
  449. Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, Krauss RM, Laufs U, Leiter LA, Marz W, Nordestgaard BG, Raal FJ, Roden M, Santos RD, Ste (2018). Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J, 39(27), 2526-2539.
     
  450. Selejan SR, Linz D, Tatu AM, Hohl M, Speer T, Ewen S, Mahfoud F, Kindermann I, Zamyatkin O, Kazakov A, Laufs U, Bohm M (2018). Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome. J Mol Cell Cardiol, 122, 34-46.
     
  451. Fuhrmann A, Weingartner O, Meyer S, Cremers B, Seiler-Mussler S, Schott HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada AM, Laufs U, Scheller B, Fliser D, Schulze PC, Bohm M, Heine GH, Lutjohann D (2018). Plasma levels of the oxyphytosterol 7?-hydroxycampesterol are associated with cardiovascular events. Atherosclerosis, 279, 17-22.
     
  452. Haas J, Mester S, Lai A, Frese KS, Sedaghat-Hamedani F, Kayvanpour E, Rausch T, Nietsch R, Boeckel JN, Carstensen A, Volkers M, Dietrich C, Pils D, Amr A, Holzer DB, Martins Bordalo D, Oehler D, Weis (2018). Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathy. EMBO Mol Med, 10(1), 107-120.
     
  453. Kavalerchyk V, Staudt A, Stoebe S, Hagendorff A, Wohlke M (2018). [Papillary Fibroelastoma of the Pulmonary and Tricuspid Valve in Asymptomatic Patients]. Dtsch Med Wochenschr, 143(20), 1484-1488.
     
  454. Steffen HJ, Kalverkamp S, Zayat R, Autschbach R, Spillner JW, Hagendorff A, Hatam N (2018). Is Systolic Right Ventricular Function Reduced after Thoracic Non-Cardiac Surgery? A Propensity Matched Echocardiographic Analysis. Ann Thorac Cardiovasc Surg, 24(5), 238-246.
     
  455. Sugimoto T, Robinet S, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena (2018). Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 19(6), 630-638.
     
  456. Galderisi M, Donal E, Magne J, Lo Iudice F, Agricola E, Sade LE, Cameli M, Schwammenthal E, Cardim N, Cosyns B, Hagendorff A, Neskovic AN, Zamorano JL, Lancellotti P, Habib G, Edvardsen T, Popescu BA (2018). Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. Eur Heart J Cardiovasc Imaging, 19(3), 245-252.
     
  457. Karliova I, Hagendorff A, Shalabi A, Schneider U, Schafers HJ (2018). Repair of a Quadricuspid Autograft. Ann Thorac Surg, 105(6), 251-253.
     
  458. Pelz JO, Harms K, Metze M, Michalski D (2018). Spontaneous cervical artery dissection is accompanied by a hypercoagulable state and simultaneous inflammatory condition. J Neurol, 265(2), 308-314.
     
  459. Wallbach M, Zurbig P, Dihazi H, Muller GA, Wachter R, Beige J, Koziolek MJ, Mischak H (2018). Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension. J Clin Hypertens (Greenwich), 20(10), 1519-1526.
     
  460. Fangauf SV, Herbeck Belnap B, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Sollner W, Wachter R, Weber CS, Herrmann-Lingen C (2018). Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients. Psychoneuroendocrinology, 96, 188-194.
     
  461. Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske (2018). Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail, 5(5), 830-841.
     
  462. Ravassa S, Trippel T, Bach D, Bachran D, Gonzalez A, Lopez B, Wachter R, Hasenfuss G, Delles C, Dominiczak AF, Pieske B, Diez J, Edelmann F (2018). Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial. Eur J Heart Fail, 20(9), 1290-1299.
     
  463. Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R (2018). Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy. Int J Cardiol, 265, 141-147.
     
  464. Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Muller-Ehmsen J (2018). Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. Int J Cardiol, 266, 187-192.
     
  465. Baldassarri F, Schwedhelm E, Atzler D, Boger RH, Cordts K, Haller B, Pressler A, Muller S, Suchy C, Wachter R, Dungen HD, Hasenfuss G, Pieske B, Halle M, Edelmann F, Duvinage A (2018). Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction. Biomarkers, 23(6), 540-550.
     
  466. Pascual-Figal D, Wachter R, Senni M, Belohlavek J, Noe A, Carr D, Butylin D (2018). Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan. ESC Heart Fail, 5(2), 327-336.
     
  467. Bobenko A, Bartels I, Munch M, Trippel T, Lindhorst R, Nolte K, Herrmann-Lingen C, Halle M, Duvinage A, Dungen HD, Gelbrich G, Tschope C, Hasenfuss G, Wachter R, Pieske B, Edelmann F (2018). Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction. ESC Heart Fail, 5(1), 53-62.
     
  468. Senni M, McMurray JJV, Wachter R, McIntyre HF, Anand IS, Duino V, Sarkar A, Shi V, Charney A (2018). Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study. Eur J Heart Fail, 20(3), 491-500.
     
  469. Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, (2018). Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 20(1), 16-37.
     
  470. Grohmann T, Penke M, Petzold-Quinque S, Schuster S, Richter S, Kiess W, Garten A (2018). Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway. Leuk Res, 69, 39-46.
     
  471. Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C (2018). Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study. Psychoneuroendocrinology, 101, 272-277.
     
  472. Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kubler WM, Mitrovic V, Riedel A, Rieth A, Schm (2018). Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018. Int J Cardiol, 272, 53-62.
     
  473. Schmidt N, Dressel A, Grammer TB, Gouni-Berthold I, Julius U, Kassner U, Klose G, Konig C, Koenig W, Otte B, Parhofer KG, Reinhard W, Schatz U, Schunkert H, Steinhagen-Thiessen E, Vogt A, Laufs U, Mar (2018). Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. Atherosclerosis, 277, 314-322.
     
  474. EAS Familial Hypercholesterolaemia Studies Collaboration (2018). Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Atherosclerosis, 277, 234-255.
     
  475. Lutjohann D, Laufs U, Schulze PC, Weingartner O (2018). Call for an ezetimibe effectiveness test. Atherosclerosis, 278, 334-.
     
  476. Neef M, Bernhardt M (2018). Erst Allgemeinzustand-Verschlechterung, dann Vigilanzstörung, letztendlich AV Block III. Grades - was ist das? In: Weber CF, Meybohm P, Marung H, Schalk R, Stehr S, Gräsner J-T,Heinrichs W, Muellenbach RM , Erfahrungsschatz Notfallmedizin (S. 99-101), Stuttgart: Thieme.
     
  477. Metze M, Petros S (2018). Spezielles Blutungsmanagement bei Lebererkrankungen Intensivmedizin V6.2 In: Eckart, Forst, Briegel, Intensivmedizin (S. 1-33), Landsberg: ecomedMEDIZIN.
     


    478. 2017


  478. Pfeiffer D, Neef M, Jurisch D, Hagendorff A (2017). Komplikationen elektrophysiologischer Eingriffe im Alter. Herzschrittmacher und Elektrophysiologie, 28(1), 3-8.
     
  479. Hagendorff A, Stoebe S, Jurisch D, Neef M, Metze M, Pfeiffer D (2017). Neues und Bewährtes in der kardiologischen Diagnostik mithilfe der TEE. Herz, 43(3), 232-240.
     
  480. Wachter R, Freedman B (2017). The role of atrial fibrillation in patients with an embolic stroke of unknown source (ESUS). Thromb Haemost, 117(10), 1833-1835.
     
  481. Weber-Kruger M, Lutz C, Zapf A, Stahrenberg R, Seegers J, Witzenhausen J, Wasser K, Hasenfuss G, Groschel K, Wachter R (2017). Relevance of supraventricular runs detected after cerebral ischemia. Neurology, 89(15), 1545-1552.
     
  482. Callizo J, Feltgen N, Ammermann A, Ganser J, Bemme S, Bertelmann T, Pfeiffer S, Duvinage A, Groschel K, Hoerauf H, Wachter R (2017). Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy. PLoS One, 12(8), e0181766.
     
  483. Wachter R, Groschel K (2017). Atrial fibrillation in high-risk patients with ischaemic stroke - Authors reply. Lancet Neurol, 16(7), 498-498.
     
  484. Wachter R, Groschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers J, Wasser K, Schulte A, Jurries F, Messerschmid A, Behnke N, Groschel S, Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko E, Heuschmann PU, Conen D, Weber-Kruger M (2017). Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol, 16(4), 282-290.
     
  485. Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim MK, Lovett EG, Schafer JE, de Leeuw PW (2017). An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems. J Am Soc Hypertens, 11(2), 81-91.
     
  486. Lavall D, Schuster P, Jacobs N, Kazakov A, Bohm M, Laufs U (2017). Rac1 GTPase regulates 11ß hydroxysteroid dehydrogenase type 2 and fibrotic remodeling. J Biol Chem, 292(18), 7542-7553.
     
  487. Adrian L, Lenski M, Todter K, Heeren J, Bohm M, Laufs U (2017). AMPK Prevents Palmitic Acid-Induced Apoptosis and Lipid Accumulation in Cardiomyocytes. Lipids, 52(9), 737-750.
     
  488. Adrian L, Werner C, Laufs U (2017). [ESC Guidelines 2016 - Heart Failure]. Dtsch Med Wochenschr, 142(15), 1123-1127.
     
  489. Perez-Ternero C, Werner CM, Nickel AG, Herrera MD, Motilva MJ, Bohm M, Alvarez de Sotomayor M, Laufs U (2017). Ferulic acid, a bioactive component of rice bran, improves oxidative stress and mitochondrial biogenesis and dynamics in mice and in human mononuclear cells. J Nutr Biochem, 48, 51-61.
     
  490. Laufs U, Jannowitz C, Pittrow D (2017). [Atorvastatin therapy under clinical practice conditions - which LDL-C levels are achieved in patients at very high cardiovascular risk?] Dtsch Med Wochenschr, 142(16), 1249-1252.
     
  491. Laufs U, Ference BA (2017). Vaccination to prevent atherosclerotic cardiovascular diseases. Eur Heart J, 38(32), 2508-2510.
     
  492. Laufs U (2017). Analysis of genes to predict the effects of proprotein convertase subtilisin/kexin type 9-inhibitors and statins. Cardiovasc Res, 113(6), e8-9.
     
  493. Laufs U, Filipiak KJ, Gouni-Berthold I, Catapano AL (2017). Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl, 26, 45-55.
     
  494. Marz W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U (2017). HDL cholesterol: reappraisal of its clinical relevance. Clin Res Cardiol, 106(9), 663-675.
     
  495. Luchner A, von Haehling S, Holubarsch C, Keller T, Knebel F, Zugck C, Laufs U (2017). [Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP]. Dtsch Med Wochenschr, 142(5), 346-355.
     
  496. Piepoli MF, Taddei S, Laufs U (2017). The year in cardiology 2016: prevention. Eur Heart J, 38(8), 542-549.
     
  497. Marz W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U (2017). [Clinical importance of HDL cholesterol]. Herz, 42(1), 58-66.
     
  498. Weingartner O, Bogeski I, Kummerow C, Schirmer SH, Husche C, Vanmierlo T, Wagenpfeil G, Hoth M, Bohm M, Lutjohann D, Laufs U (2017). Plant sterol ester diet supplementation increases serum plant sterols and markers of cholesterol synthesis, but has no effect on total cholesterol levels. J Steroid Biochem Mol Biol, 169, 219-225.
     
  499. Meyer-Saraei R, de Waha S, Eitel I, Desch S, Scheller B, Bohm M, Lauer B, Gawaz M, Geisler T, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Zeymer U, Thiele H (2017). Thrombus aspiration in non-ST-elevation myocardial infarction - 12-month clinical outcome of the randomised TATORT-NSTEMI trial. Eur Heart J Acute Cardiovasc Care, 6(1), 10-17.
     
  500. Zwirner J, Bayer R, Hadrich C, Bollmann A, Klein N, Dressler J, Ondruschka B (2017). Pulmonary artery perforation and coronary air embolism-two fatal outcomes in percutaneous left atrial appendage occlusion. Int J Legal Med, 131(1), 191-197.
     
  501. Trippel TD, Holzendorf V, Halle M, Gelbrich G, Nolte K, Duvinage A, Schwarz S, Rutscher T, Wiora J, Wachter R, Herrmann-Lingen C, Duengen HD, Hasenfuss G, Pieske B, Edelmann F (2017). Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study. ESC Heart Fail, 4(1), 56-65.
     
  502. Luers C, Trippel TD, Seelander S, Wachter R, Hasenfuss G, Lindhorst R, Bobenko A, Nolte K, Pieske B, Edelmann F (2017). Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study. J Am Soc Hypertens, 11(5), 303-313.
     
  503. Luers C, Edelmann F, Wachter R, Pieske B, Mende M, Angermann C, Ertl G, Dungen HD, Stork S (2017). Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure. Clin Cardiol, 40(9), 667-673.
     
  504. Wild PS, Felix JF, Schillert A, Teumer A, Chen MH, Leening MJG, Volker U, Grossmann V, Brody JA, Irvin MR, Shah SJ, Pramana S, Lieb W, Schmidt R, Stanton AV, Malzahn D, Smith AV, Sundstrom J, Minelli (2017). Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest, 127(5), 1798-1812.
     
  505. Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, Pouliot E, Ziegler PD (2017). Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study. JAMA Cardiol, 2(10), 1120-1127.
     
  506. Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu (2017). Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 18(8), 833-840.
     
  507. Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G, Donal E, Sade LE, Ernande L, Garbi M, Grapsa J, Hagendorff A, Kamp O, Magne J, Santoro C, Stefanidis A, Lancellotti P, Popescu B, H (2017). Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 18(12), 1301-1310.
     
  508. Rasche FM, Stoebe S, Ebert T, Feige S, Hagendorff A, Rasche WG, Barinka F, Busch V, Sack U, Schneider JG, Schiekofer S (2017). Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients. BMC Nephrol, 18(1), 175.
     
  509. Lancellotti P, Galderisi M, Edvardsen T, Donal E, Goliasch G, Cardim N, Magne J, Laginha S, Hagendorff A, Haland TF, Aaberge L, Martinez C, Rapacciuolo A, Santoro C, Ilardi F, Postolache A, Dulgheru R (2017). Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Heart J Cardiovasc Imaging, 18(9), 961-968.
     
  510. Cadeddu C, Piras A, Dessi M, Madeddu C, Mantovani G, Scartozzi M, Hagendorff A, Colonna P, Mercuro G (2017). Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy. Int J Cardiovasc Imaging, 33(2), 197-207.
     
  511. Mueller UM, Walther C, Adam J, Fikenzer K, Erbs S, Mende M, Adams V, Linke A, Schuler G (2017). Endothelial Function in Children and Adolescents Is Mainly Influenced by Age, Sex and Physical Activity?- An Analysis of Reactive Hyperemic Peripheral Artery Tonometry. Circ J, 81(5), 717-725.
     
  512. Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A (2017). Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. J Atr Fibrillation, 9(5), 1551.
     
  513. Zelenak C, Radenovic S, Musial-Bright L, Tahirovic E, Sacirovic M, Lee CB, Jahandar-Lashki D, Inkrot S, Trippel TD, Busjahn A, Hashemi D, Wachter R, Pankuweit S, Stork S, Pieske B, Edelmann F, Dungen (2017). Heart failure awareness survey in Germany: general knowledge on heart failure remains poor. ESC Heart Fail, 4(3), 224-231.
     
  514. Maier IL, Schregel K, Karch A, Weber-Krueger M, Mikolajczyk RT, Stahrenberg R, Groschel K, Bahr M, Knauth M, Psychogios MN, Wachter R, Liman J (2017). Association between Embolic Stroke Patterns, ESUS Etiology, and New Diagnosis of Atrial Fibrillation: A Secondary Data Analysis of the Find-AF Trial. Stroke Res Treat, 2017, 1391843.
     
  515. Wandelt LK, Kowallick JT, Schuster A, Wachter R, Stumpfig T, Unterberg-Buchwald C, Steinmetz M, Ritter CO, Lotz J, Staab W (2017). Quantification of left atrial volume and phasic function using cardiovascular magnetic resonance imaging-comparison of biplane area-length method and Simpsons method. Int J Cardiovasc Imaging, 33(11), 1761-1769.
     
  516. Edelmann F, Bobenko A, Gelbrich G, Hasenfuss G, Herrmann-Lingen C, Duvinage A, Schwarz S, Mende M, Prettin C, Trippel T, Lindhorst R, Morris D, Pieske-Kraigher E, Nolte K, Dungen HD, Wachter R, Halle (2017). Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial. Eur J Heart Fail, 19(8), 1067-1074.
     
  517. Uphaus T, Grings A, Groschel S, Muller A, Weber-Kruger M, Wachter R, Groschel K (2017). Automatic detection of paroxysmal atrial fibrillation in patients with ischaemic stroke: better than routine diagnostic workup? Eur J Neurol, 24(7), 990-994.
     
  518. Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice (2017). Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation, 135(9), 1851-1867.
     
  519. Hoeper MM, Lam CSP, Vachiery JL, Bauersachs J, Gerges C, Lang IM, Bonderman D, Olsson KM, Gibbs JSR, Dorfmuller P, Guazzi M, Galie N, Manes A, Handoko ML, Vonk-Noordegraaf A, Lankeit M, Konstantinides (2017). Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research. Eur Heart J, 38(38), 2869-2873.
     
  520. Geisler T, Poli S, Meisner C, Schreieck J, Zuern CS, Nagele T, Brachmann J, Jung W, Gahn G, Schmid E, Baezner H, Keller T, Petzold GC, Schrickel JW, Liman J, Wachter R, Schon F, Schabet M, Lindner A, (2017). Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design. Int J Stroke, 12(9), 985-990.
     
  521. Jahandar Lashki D, Zelenak C, Tahirovic E, Trippel TD, Kolip P, Busjahn A, Rauchfuss M, Nolte K, Schwarz S, Wachter R, Gelbrich G, Halle M, Pieske B, Herrmann-Lingen C, Edelmann F, Dungen HD (2017). [Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire]. Herz, 42(2), 200-208.
     
  522. Vukadinovic D, Lavall D, Vukadinovic AN, Pitt B, Wagenpfeil S, Bohm M (2017). True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis. Am Heart J, 188, 99-108.
     
  523. Ference BA, Kastelein JJP, Ginsberg HN, Chapman MJ, Nicholls SJ, Ray KK, Packard CJ, Laufs U, Brook RD, Oliver-Williams C, Butterworth AS, Danesh J, Smith GD, Catapano AL, Sabatine MS (2017). Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. JAMA, 318(10), 947-956.
     
  524. Bohm M, Laufs U, Mahfoud F, Schirmer SH, Kindermann I (2017). Primum non nocere: the dangers of deferring heart failure therapy. Eur J Heart Fail, 19(11), 1410-1411.
     
  525. Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, B (2017). Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes Endocrinol, 5(7), 534-543.
     
  526. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Boren J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Slu (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 38(32), 2459-2472.
     
  527. Glerup S, Schulz R, Laufs U, Schluter KD (2017). Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease. Basic Res Cardiol, 112(3), 32.
     
  528. Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, (2017). Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur Heart J, 38(20), 1597-1607.
     
  529. Scherer N, Dings C, Bohm M, Laufs U, Lehr T (2017). Alternative Treatment Regimens With the PCSK9 Inhibitors Alirocumab and Evolocumab: A Pharmacokinetic and Pharmacodynamic Modeling Approach. J Clin Pharmacol, 57(7), 846-854.
     
  530. Kohlhaas M, Nickel AG, Bergem S, Casadei B, Laufs U, Maack C (2017). Endogenous nitric oxide formation in cardiac myocytes does not control respiration during ß-adrenergic stimulation. J Physiol, 595(12), 3781-3798.
     
  531. Oesterle A, Laufs U, Liao JK (2017). Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res, 120(1), 229-243.
     
  532. Schwarz V, Bachelier K, Schirmer SH, Werner C, Laufs U, Bohm M (2017). Red Wine Prevents the Acute Negative Vascular Effects of Smoking. Am J Med, 130(1), 95-100.
     
  533. Pusceddu I, Herrmann M, Kirsch SH, Werner C, Hubner U, Bodis M, Laufs U, Widmann T, Wagenpfeil S, Geisel J, Herrmann W (2017). One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation. Eur J Nutr, 56(5), 1887-1898.
     
  534. Schott HF, Baumgartner S, Husche C, Luister A, Friedrichs S, Miller CM, McCarthy FO, Plat J, Laufs U, Weingartner O, Lutjohann D (2017). Oxidation of sitosterol and transport of its 7-oxygenated products from different tissues in humans and ApoE knockout mice. J Steroid Biochem Mol Biol, 169, 145-151.
     
  535. Hagendorff A (2017). System diseases and other conditions: Introduction./ Diseases with a main influence on heart valves./ Diseases with a main influence on Pericardium./ Coronary artery Imaging. In: Lancellotti P, Zamorano JL, Habib G, Badano L, The EACVI textbook of echocardiography (S. 472, 497-504, 597-60), Oxford: Oxford University Press.
     
  536. Hagendorff A, Stöbe S (2017). Basiswissen Echokardiographie. In: Hagendorff A, Stöbe S, Basiswissen Echokardiographie. (S. 1-392), München: Urban und Fischer Verlag/Elsevier GmbH.
     


    537. 2016


  537. Klein N, Pfeiffer D, Klein M (2016). Right apical, biventricular and right high septal ventricular pacing: A comparison of procedural burden and long term electrical performance. Archives of Medicine, 8, 1-11.
     
  538. Salameh A, Dhein S, Dahnert I, Klein N (2016). Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass. Int J Mol Sci, 17(11), 1945.
     
  539. Pfeiffer D, Jurisch D, Neef M, Hagendorff A (2016). [Alcohol and arrhythmias]. Herz, 41(6), 498-502.
     
  540. Klein N, Pfeiffer D, Goldberg S, Klein M (2016). Mitral Annuloplasty Device Implantation for Non-Surgical Treatment of Mitral Regurgitation: Clinical Experience After the Approval Studies. J Invasive Cardiol, 28(3), 115-120.
     
  541. Hagendorff A, Stöbe S (2016). Kontrastechokardiographie in der klinischen Praxis. Forum Sanitas, 4, 2-4.
     
  542. Waltenberger J, Brachmann J, van der Heyden J, Richardt G, Frobert O, Seige M, Erglis A, Dewilde W, Winkens M, Hegeler-Molkewehrum C, Klein N, Hoffmann S (2016). Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry. EuroIntervention, 11(10), 1106-1110.
     
  543. Asbach S, Lennerz C, Semmler V, Grebmer C, Solzbach U, Kloppe A, Klein N, Szendey I, Andrikopoulos G, Tzeis S, Bode C, Kolb C (2016). Impact of the Right Ventricular Lead Position on Clinical End Points in CRT Recipients--A Subanalysis of the Multicenter Randomized SPICE Trial. Pacing Clin Electrophysiol, 39(3), 261-267.
     
  544. Khamis H, Shimoni S, Hagendorff A, Smirin N, Friedman Z, Adam D (2016). Optimization-Based Speckle Tracking Algorithm for Left Ventricle Strain Estimation: A Feasibility Study. IEEE Trans Ultrason Ferroelectr Freq Control, 63(8), 1093-1106.
     
  545. Hobohm C, Hagendorff A, Schulz S, Fritzsch D, Budig S, Stobe S, Michalski D (2016). Clinical Presentation and Multi-Parametric Screening Surrogates of Ischemic Stroke Patients Suffering from Infective Endocarditis. Cerebrovasc Dis, 41(1-2), 60-67.
     


    546. 2015


  546. Hagendorff, A, Stoebe S, Jurisch D, Tarr A, Pfeiffer D (2015). Echokardiographische Parameter bei der diastolischen Herzinsuffizienz. Kardiologie up2date, 11(3), 133-136.
     
  547. Hagendorff A, Stoebe S, Tarr A, Pfeiffer D (2015). Standardized Transthoracic Echocardiography in Patients with Primary and Secondary Mitral Valve Regurgitation. Ultraschall Med, 36(1), 10-34.
     
  548. Pfeiffer D, Hagendorff A, Kuhne C, Reinhardt S, Klein N (2015). [Implantable cardioverter-defibrillator at the end of life]. Herzschrittmacherther Elektrophysiol, 26(2), 134-140.
     
  549. Reske AP, Reske AW, Metze M (2015). Complications of immunosuppressive agents therapy in transplant patients. Minerva Anaesthesiologica , 81(11), 1244-1261.
     
  550. Reinecke H, Braun M, Frankenstein L, Görge G, Kerlin A, Knoblich A, Kodolitsch Y von, Lengenfelder B, Levenson B, Pfeiffer D, Reichle B, (2015). Kriterien für die Notwendigkeit und Dauer von Krankenhausbehandlung bei Koronarographien und -interventionen. Der Kardiologe, 9(4), 295-302.
     
  551. Hammer N, Glatzner J, Feja C, Kuhne C, Meixensberger J, Planitzer U, Schleifenbaum S, Tillmann BN, Winkler D (2015). Human vagus nerve branching in the cervical region. PLoS One, 10(2), e0118006.
     
  552. Hammer N, Kuhne C, Meixensberger J, Hansel B, Winkler D (2015). Takotsubo cardiomyopathy - An unexpected complication in spine surgery. Int J Surg Case Rep, 6C, 172-174.
     
  553. Andrikopoulos G, Tzeis S, Asbach S, Semmler V, Lennerz C, Solzbach U, Grebmer C, Kloppe A, Klein N, Pastromas S, Biermann J, Kolb C (2015). A stepwise electrocardiographic algorithm for differentiation of mid-septal vs. apical right ventricular lead positioning: the SPICE ECG substudy. Europace, 17(6), 915-920.
     
  554. Loeffler M, Engel C, Ahnert P, Alfermann D, Arelin K, Baber R, Beutner F, Binder H, Brahler E, Burkhardt R, Ceglarek U, Enzenbach C, Fuchs M, Glaesmer H, Girlich F, Hagendorff A, Hantzsch M, Hegerl U, (2015). The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. BMC Public Health, 15, 691.
     
  555. Zimmer J, Hawlitschek C, Rabald S, Hagendorff A, Zimmer HG, Rassler B (2015). Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies. Hypertens Res, 38(11), 716-722.
     
  556. Caballero L, Kou S, Dulgheru R, Gonjilashvili N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Oliva MJ, Hagendorff A, Hristova K, Lopez T, Magne J, Martinez C, de la Morena G, (2015). Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Heart J Cardiovasc Imaging, 16(9), 1031-1041.
     
  557. Cardim N, Galderisi M, Edvardsen T, Plein S, Popescu BA, D Andrea A, Bruder O, Cosyns B, Davin L, Donal E, Freitas A, Habib G, Kitsiou A, Petersen SE, Schroeder S, Lancellotti P, Camici P et al (2015). Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging, 16(3), 280.
     
  558. Hobohm C, Hagendorff A, Schulz S, Fritzsch D, Budig S, Stoebe S, Michalski D (2015). Clinical Presentation and Multi-Parametric Screening Surrogates of Ischemic Stroke Patients Suffering from Infective Endocarditis Cerebrovasc Dis, 41(1-2), 60-67.
     
  559. Hagendorff A (2015). Conventional echocardiography - Basic principles. In: Zamorano JL, Bax J, Knuuti J, Sechtem U, Lancelotti P, Badano L, The ESC textbook of cardiovascular imaging. (S. 3-32), Oxford: Oxford university press.
     
  560. Hagendorff A, Stoebe St (2015). Basics in transthoracic echocardiography and Standard documentation. In: Dietrich CF, EFSUMB Course book. (S. 2-21), London: EFSUMB.
     


    561. 2014


  561. Hagendorff A, Tiemann K, Simonis G, Campo dell´Orto M, von Bardeleben S (2014). Empfehlungen zur Notfallechokardiographie. Kardiologe, 8(1), 45-64.
     
  562. Stoebe S, Tarr A, Pfeiffer D, Hagendorff A (2014). The impact of width of the tracking area on the speckle tracking parameters - methodological aspects of deformation imaging. Echocardiography , 31(5), 586-596.
     
  563. Pfeiffer D, Jurisch D, Kluge JG, Hagendorff A, Klein N (2014). Medikamentöse Therapie des Vorhofflimmerns in speziellen Situationen Herzschrittmacher Elektrophysiol, 25(1), 26-32.
     
  564. Hagendorff A (2014). Coronary calcium score - does it matter in asymptomatic patients? - Contra view Eur Heart J, 35(20), 1296-1297.
     
  565. Stoebe S, Pfeiffer D, Hagendorff A (2014). Feasibility of 3D4D echocardiography for the detection of color-coded flow in the left anterior descendng artery echo research and practice, 1(1), 23-30.
     
  566. Trache T, Stoebe S, Tarr A, Pfeiffer D, Hagendorff A (2014). The agreement between 3D, standard 2D and triplane 2D speckle tracking: Effects of image quality and 3D volume rate Echo research and practice, 1(2), 71-83.
     
  567. Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez De Diego JJ, Hagendorff A, Henri C, Hristova K, Lopez T, Magne J, De La Mor (2014). Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. Eur Heart J Cardiovasc Imaging, 15(6), 680-690.
     
  568. Neskovic A, Edvardsen T, Galderisi M, Garbi M, Gullace G, Jurcut R, Dalen H, Hagendorff A, Lancelotti P (2014). Focus cardiac ultrasound: The European Association of cardiovascular ultrasound viewpoint. Eur Heart J Cardiovasc Imag, 15(9), 956-960.
     
  569. Doenst T, Amorim PA, Hagendorff A, Faerber G, Graff J, Rastan A, Deutsch O, Eichinger W (2014). Novel thoughts on patient-prosthesis mismatch in aortic valve replacement: the rationale for the PAR I trial. Thorac Cardiovasc Surg, 62(6), 463-468.
     
  570. Thiele H, de Waha S, Zeymer U, Desch S, Scheller B, Lauer B, Geisler T, Gawaz M, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Eitel I (2014). Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial JACC, 64(11), 1117-1124.
     
  571. Wiltberger G, Schmelzle M, Schubert S, Lubbert C, Brandmaier P, Berg T, Pfeiffer D, Rodloff A, Mohr FW, Jonas S (2014). Invasive cardiac aspergillosis after orthotopic liver transplantation. Z Gastroenterol, 52(8), 813-817.
     
  572. Tzeis S, Andrikopoulos G, Asbach S, Semmler V, Lennerz C, Solzbach U, Vrazic H, Kloppe A, Klein N, Pastromas S, Biermann J, Kolb C (2014). Electrocardiographic identification of prior myocardial infarction during right ventricular pacing - Effect of septal versus apical pacing. Int J Cardiol, 177(3), 977-981.
     
  573. Kolb C, Solzbach U, Biermann J, Semmler V, Kloppe A, Klein N, Lennerz C, Szendey I, Andrikopoulos G, Tzeis S, Asbach S (2014). Safety of mid-septal electrode placement in implantable cardioverter defibrillator recipients--results of the SPICE (Septal Positioning of ventricular ICD Electrodes) study. Int J Cardiol, 174(3), 713-720.
     
  574. Hammer N, Kuhne C, Meixensberger J, Hansel B, Winkler D (2014). Takotsubo cardiomyopathy - An unexpected complication in spine surgery. Int J Surg Case Rep, 6C, 172-174.
     


    575. 2013


  575. Jurisch D, Kluge JG, Pfeiffer D (2013). Akutes Rechtsherzversagen nach intravenöser Injektion von Heroin und Flunitrazepam. Dtsch Med Wochenschr, 138(22), 1159-1162.
     
  576. Hagendorff A, Stobe S, Tarr A, Pfeiffer D (2013). [Special echocardiographic diagnosis and specific problem constellations in patients with degenerative stenosis of the aortic valve]. Ultraschall Med, 34(3), 214-232.
     
  577. Hagendorff A, Freytag S, Muller A, Klebs S (2013). Pill burden in hypertensive patients treated with single-pill combination therapy-an observational study. Adv Ther, 30(4), 406-419.
     
  578. Hagendorff A (2013). Herz-Ultraschall auf dem Vormarsch? Management und Krankenhaus, 11, 12.
     
  579. Pfeiffer D, von Kodolitsch Y, Schächinger V, Haude M, Willems S, Nowak B (2013). Stellungnahme der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung zur Durchführung elektiver kardiovaskulärer Interventionen am Aufnahmetag. Kardiologe, 7(6), 423-428.
     
  580. Klein N, Klein M, Pfeiffer D (2013). Schrittmacher, kardiale Resynchronisation, implantierbarer Kardioverter/Defibrillator, Eventmonitoring. Dtsch Med Wochenschr, 138(49), 2526-2529.
     
  581. Tarr A, Stobe S, Trache T, Kluge JG, Varga A, Pfeiffer D, Hagendorff A (2013). The impact of foreshortening on regional strain--a comparison of regional strain evaluation between speckle tracking and tissue velocity imaging. Ultraschall Med, 34(5), 446-453.
     
  582. Hagendorff A, Stöbe S (2013). Notfall-Echokardiographie. Kardiologie up2date, 9(2), 119-129.
     
  583. Hagendorff A, Stöbe S (2013). Hypertrophe Kardiomyopathie. Wie sinnvoll ist ein systematisches Screening mittels Ultraschall. medicalsports network, 5, 2-6.
     
  584. de Waha S, Eitel I, Desch S, Scheller B, Böhm M, Lauer B, Gawaz M, Geisler T, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Zeymer U, Thiele H (2013). Thrombus aspiration in thrombus containing culprit lesion in non ST elevation myocardial infarction: study protocol for a randomized controlled trial Trials , 14, 110.
     
  585. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL (2013). Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 14(7), 611-644.
     
  586. Lancellotti P, Badano LP, Lang RM, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Derumeaux G, Dulgheru R, Edvardsen T, Galderisi M, Goncalves A, Habib G, Hagendorff (2013). Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study). Eur Heart J Cardiovasc Imaging, 14(4), 303-308.
     
  587. Neskovic AN, Hagendorff A, Lancellotti P, Guarracino F, Varga A, Cosyns B, Flachskampf FA, Popescu BA, Gargani L, Zamorano JL, Badano LP (2013). Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations. Eur Heart J Cardiovasc Imaging, 14(1), 1-11.
     
  588. Pfeiffer D, Klein N, Hagendorff A (2013). Akute Linksherzinsuffizienz. In: Kluge S, Markewitz A, Muhl E, Outensen C, Quintel M, Sybrecht GW, DIVI Jahrbuch 2013/2014: Fortbildung und Wissenschaft in der interdiszipülinären Intensivmedizin und Notfallmedizin. (S. 115-118), Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft.
     
  589. Hagendorff A (2013). Thoraxschmerz. In: Blank W, Mathis G, Osterwalder J, Kursbuch Notfallsonographie. (S. 127-135), Stuttgart, New York: Georg Thieme Verlag.
     
  590. Hagendorff A (2013). Anatomie, Normalbefunde, Standardschnitte - Teil 2. In: Blank W, Mathis G, Osterwalder J, Kursbuch Notfallsonographie. (S. 206-212), Stuttgart, New York: Georg Thieme Verlag.
     


    591. 2012


  591. Pfeiffer D, Rennie N, Papst CC, Zhang J (2012). Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Patients who did not Respond Fully to Amlodipine Monotherapy¥. Curr Vasc Pharmacol, 10(6), 773-80.
     
  592. Hagendorff A, Stöbe S, Tarr A, Pfeiffer D (2012). Die konventionelle Standarduntersuchung in der transthorakalen Echokardiographie bei Patienten mit degenerativer Aortenstenose. Ultraschall Med, 33(6), 520-43.
     
  593. Hagendorff A, Wüstenfeld J (2012). Herzultraschall - Möglichkeiten zur Diagnose einer nichtphysiologischen Wandverdickung. medical sports network, 1, 4-6.
     
  594. Hagendorff A (2012). Echokardiographische Notfalldiagnostik. Herz, 37(6), 675-86.
     
  595. Hagendorff A, Stoebe S, Tarr A, Pfeiffer D (2012). [Standard transthoracic echocardiography examination in patients with degenerative stenosis of the aortic valve] Ultraschall Med, 33(6), 520-543.
     
  596. Thiele H, Rach J, Klein N, Pfeiffer D, Hartmann A, Hambrecht R, Sick P, Eitel I, Desch S, Schuler G (2012). Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J , 33(16), 2035-2043.
     
  597. Klein N, Klein M, Weglage H, Przibille O, Fischer S, Trappe HJ, Birkenhauer F, Pfeiffer D (2012). Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: Insights from the efface Phrenic Stim study. Europace, 14(6), 826-32.
     
  598. Carlsson J, Paul NW, Dann M, Neuzner J, Pfeiffer D (2012). The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations. Dtsch Ärztebl Int , 109(33-34), 535-541.
     
  599. Nickl W, Fürth R, Smettan J, Köhler T, Lankisch M, Kramer F, Barrose MC, Klein RM, Dinh W (2012). Assessment of aortic valve area combining echocardiography and magnetic resonance imaging. Arg Bras Cardiol, 98(3), 234-42.
     


    600. 2011


  600. Kluge JG, Jurisch D, Tarr A, Hagendorff A, Pfeiffer D (2011). Right atrial free floating thrombus in dilated cardiomyopathy. Eur J Echocardiograph, 12(10), 798.
     
  601. Kluge JG, Hagendorff A, Pfeiffer D, Jurisch D, Tarr A (2011). Active infective prosthetic endocarditis after percutaneous edge-to-edge mitral valve repair. Eur J Echocardiogr, 12(10), 710.
     
  602. Dhein S, Rothe S, Busch A, Rojas Gomez DM, Boldt A, Reutemann A, Seidel T, Salameh A, Pfannmüller B, Rastan A, Kostelka M, Mohr FW (2011). Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation. Br J Pharmacol , 164(2b), 607-16.
     
  603. Thiele H, Eitel I, Meinberg C, Desch S, Leuschner A, Pfeiffer D, Hartmann A, Lotze U, Strauss W, Schuler G (2011). Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc Intervent, 4(6, 605-614.
     
  604. Salameh A, Klein M, Klein N, Pfeiffer D, Dähnert I, Dhein S (2011). Coughing into the darkness. Lancet, 377(9778), 1718.
     
  605. Dinh W, Nickl W, Smettan J, Koehler T, Bansemir L, Lankisch M, Scheffold T, Barroso MC, Gülker JE, Füth R (2011). Relation of global longitudinal strain to left ventricular geometry in aortic stenosis. Cardiol J, 18(2), 151-6.
     
  606. Gehoff A, Kluge JG, Gehoff P, Jurisch D, Pfeiffer D, Hinz J, Popow AF (2011). Recurrent strokes under antiocoagulation therapy: Sticky platelet syndrom combined with patent foramen ovale. J Cardiovasc Dis Res, 2(1), 68-70.
     
  607. Hagendorff A (2011). Cardiac involvement in systemic diseases (chapter 18). In: Luigi Badano, The EAE Textbook of Echocardiography. (S. 1-18), Oxford: Oxford University Press.
     
  608. Neskovic AN, Hagendorff A (2011). Echocardiography in the Emergency room (chapter 24). In: Luigi Badano, The EAE Textbook of Echocardiography. (S. 1-13), Oxford: Oxford University Press.
     


    609. 2010


  609. Kluge JG, Körner I, Kluge G, Froster U, Pfeiffer D (2010). 35-year old patient with severe thromboembolism Internist, 51(12), 1567-1570.
     
  610. Kamper L, Smettan J, Abanador-Kamper N, Piroth W, Haltern G, Haage P (2010). Multimodal visualizaion of a retrocardial bronchial artery aneurysm with rare origin from the distal descending aorta. Clin Res Cardiol, 99(1), 51-52.
     
  611. Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Hijazi Z, Jung C, Lauten A, Figulla HR (2010). The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol, 22(4), 182-7.
     
  612. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL (2010). European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr, 11(4), 307-32.
     
  613. Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E, Monin JL, Pierard LA, Badano L, Zamorano JL (2010). European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr, 11(3), 223-44.
     
  614. Schuler A, Reuss J, Delorme S, Hagendorff A, Giesel F (2010). Costs of clinical ultrasound examinations - an economical cost calculation and analysis. Ultraschall Med, 31(4), 379-86.
     
  615. Buck T, Breithardt OA, Faber L, Fehske W, Flachskampf FA, Franke A, Hagendorff A, Hoffmann R, Kruck I, Kücherer H, Menzel T, Pethig K, Tiemann K, Voigt JU, Weidemann F, Nixdorff U (2010). Erratum zu: Manual zur Indikation und Durchführung der Echokardiographie Clin Res Cardiol, 99(1), 63.
     
  616. Dinh W, Nickl W, Smettan J, Kramer F, Krahn T, Scheffold T, Barroso MC, Brinkmann H, Koehler T, Lankisch M, Füth R (2010). Reduced global longitudinal strain in association to increased left ventricular mass in patients with aortic valve stenosis and normal ejection fraction: a hybrid study combining echocardiography and magnetic resonance imaging Cardiovasc Ultrasound, 8, 29 ff.
     
  617. Flachskampf FA, Hagendorff A (2010). Koronare Herzkrankheit: Der Ischämienachweis ist der Angelpunkt der Diagnostik Deutsches Ärzteblatt, 107(34-35), 1627-32.
     


    618. 2009


  618. Jurisch D, Hagendorff A, Pfeiffer D (2009). [Do results of transoesophageal echocardiography during closure of patent foramen ovale influence interventional therapy?] Ultraschall Med, 30(1), 64-70.
     
  619. Pfeiffer D, Tebbenjohanns J (2009). [Herzchrittmachertherapie und Elektrophysiologie. Editorial] Herzschrittmacherther Elektrophysiol, 20(1), 3-4.
     
  620. Klein M, Klein N, Pfeiffer D (2009). Atriale Stimulation zur Prävention von Vorhofflimmern : Einfluss der septalen atrialen Stimulation mit atrialer Überstimulation und optimierter AV-Zeit auf die Vorhofflimmerlast Herzschrittmacherther Elektrophysiol, 20(3), 148-153.
     
  621. Pfeiffer D, Oeff, M (2009). Telemonitoring Herzschrittmacherther Elektrophysiol, 20(4), 163.
     
  622. Hemmer W, Rybak K, Markewitz A, Israel C, Kramer LI, Neuzner J, Nowak B, Pfeiffer D, Schuchert A, Wiegand U (2009). [Empfehlungen zur Strukturierung der Herzschrittmacher- und Defibrillatortherapie.] Thorac Cardiovasc Surg, 57(1), 1-10.
     
  623. Buck T, Breithardt OA, Faber T, Fehske W, Flachskampf FA, Franke A, Hagendorff A, Hoffmann R, Kruck I, Kücherer H, Menzel T, Pethig K, Thiemann K, Voigt JU, Weidemann F, Nixdorf U (2009). Manual zur Indikation und Durchführung der Echokardiographie. Clin Res Cardiol , Suppl. 4, 3-51.
     
  624. Salameh A, Krautblatter S, Karl S, Blanke K, Gomez DR, Dhein S, Pfeiffer D, Janousek J (2009). The signal transduction cascade regulating the expression of the gap junction protein connexin43 by beta-adrenoceptors. Br J Pharmacol, 158(1), 198-208.
     
  625. Schwab JO, Müller A, Oeff M, Neuzner J, Sack S, Pfeiffer D, Zugck C (2009). TeleMonitoring Systeme in der Kardiologie: Erfordernisse, Realisierungen, Zukunftsperspektiven. In: DGBMT, Tagungsband. (S. 1-47), Frankfurt: Verband der Elektrotechnik, Elektronik, Informatio.
     
  626. Hagendorff A (2009). kommentierte Video-loops auf der DVD. In: Neskovic AN, Flachskampf FA, Stress Echocardiography. Essential Guide and DVD. (S. 53-209), New York: Informa Healthcare.
     


    627. 2008


  627. Schneider HJ, Rossner S, Pfeiffer D, Hagendorff A (2008). d-ribose improves cardiac contractility and hemodynamics, and reduces expression of c-fos in the hippocampus during sustained slow ventricular tachycardia in rats. Int J Cardiol, 125(1), 49-56 .
     
  628. Kimmel S, Pfeiffer D, Schwarz J (2008). [Syncope. A diagnostic challenge.] Internist (Berl), 49(2), 185-198.
     
  629. Hagendorff A (2008). Transthoracic echocardiography in adult patients--a proposal for documenting a standardized investigation. Ultraschall Med, 29(4), 344-365.
     
  630. Hagendorff A, Kruck I, Merz E (2008). [Echocardiography: quo vadis?] Ultraschall Med, 29(2), 208-209.
     
  631. Salameh A, Krautblatter S, Baessler S, Karl S, Rojas Gomez D, Dhein S, Pfeiffer D (2008). Signal transduction and transcriptional control of cardiac connexin43 up-regulation after alpha 1-adrenoceptor stimulation. J Pharmacol Exp Ther, 326(1), 315-322.
     
  632. Schwab JO, Muller A, Oeff M, Neuzner J, Sack S, Pfeiffer D, Zugck C (2008). [Latest proceedings: remote medicine - ready for clinical practice?!] Herz, 33(6), 420-430.
     
  633. Oeff M, Muller A, Neuzner J, Sack S, Schwab JO, Pfeiffer D, Zugck C (2008). [ECG telemonitoring] Herzschrittmacherther Elektrophysiol, 19(3), 137-145.
     
  634. Muller A, Schwab JO, Oeff M, Neuzner J, Sack S, Pfeiffer D, Zugck C (2008). [Telemedicine--ready for use in the cardiological field?] Dtsch Med Wochenschr, 133(40), 2039-2044.
     
  635. Jurisch D, Szokodi D, Pfeiffer D, Kahn T, Engelmann L (2008). [A 49-year-old woman with deep vein thrombosis, pulmonary embolism, and left-sided paralysis] Internist (Berl), 49(10), 1251-1252.
     
  636. Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Figulla HR (2008). Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO). Clin Res Cardiol, 97(12), 872-877.
     
  637. Watz H, Oltmanns A, Kimmel S, Magnussen H, Wirtz H, Kirsten D (2008). [Sporadic lymphangioleiomyomatosis. Clinical and lung functional characteristics of 32 female patients] Dtsch Med Wochenschr, 133(14), 705-708.
     


    638. 2007


  638. Schauer J (2007). Nachruf für Prof. Dr. med. Werner Ries Ärzteblatt Sachsen, 18(10), 534.
     
  639. Resetar ME, Ullmann C, Broeske P, Ludwig-Schindler K, Doll NK, Salameh A, Dhein S, Mohr FW (2007). Selective arterialization of a cardiac vein in a model of cardiac microangiopathy and macroangiopathy in sheep. J Thorac Cardiovasc Surg, 133(5), 1252-1256.
     
  640. Rabald S, Hagendorff A, Pfeiffer D, Zimmer HG, Deten A (2007). Contrast enhanced echocardiographic follow-up of cardiac remodeling and function after myocardial infarction in rats. Ultrasound Med Biol, 33(10), 1561-1571.
     
  641. Krug S, Seyfarth HJ, Hagendorff A, Wirtz H (2007). Inhaled iloprost for hepatopulmonary syndrome: improvement of hypoxemia. Eur J Gastroenterol Hepatol, 19(12), 1140-1143.
     
  642. Rassler B, Hallebach G, Kalischewski P, Baumann I, Schauer J, Spengler CM (2007). The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscul Disord, 17(5), 385-391.
     


    643. 2006


  643. Salameh A, Frenzel C, Boldt A, Rassler B, Glawe I, Schulte J, Muhlberg K, Zimmer HG, Pfeiffer D, Dhein S (2006). Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression. FASEB J, 20(2), 365-367.
     
  644. Klein N, Klein M, Salameh A, Pfeiffer D (2006). [Modern pacing therapy.] Internist (Berl), 47(10), 1024-1033.
     
  645. Teich N, Engelmann L, Pfeiffer D (2006). Laienreanimation: schlechte Kenntnisse in Deutschland. Der Notarzt, 22(4), 114-118.
     
  646. Kuhn H, Konrad J, Holtz S, Salameh A, Gessner C, Hammerschmidt S, Wirtz H (2006). Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines. Lung Cancer, 54(2), 149-153.
     
  647. Kolb C, Wille B, Maurer D, Schuchert A, Weber R, Schibgilla V, Klein N, Hummer A, Schmitt C, Zrenner B (2006). Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study. J Cardiovasc Electrophysiol, 17(9), 992-997.
     
  648. Thiele H, Scholz M, Engelmann L, Storch WH, Hartmann A, Dimmel G, Pfeiffer D, Schuler G, Leipzig Prehospital Fibrinolysis Group (2006). ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol, 98(9), 1132-1139.
     
  649. Thiele H, Scholz M, Engelmann L, Storch WH, Hartmann A, Dimmel G, Pfeiffer D, Schuler G (2006). ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol, 98(9), 1132-1139.
     
  650. Kuhn H, Konrad J, Holtz S, Salameh A, Gessner C, Hammerschmidt S, Wirtz H (2006). Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines. Lung Cancer, 54(2), 149-153.
     
  651. Mende L, Böhm R, Regenthal R, Klein N, Grond S, Radke J (2006). Hyperdynamischer Kreislaufstillstand nach Ingestion von Ecstasy. Notfall & Hausarztmedizin, 32(3), 154-157.
     
  652. Pfeiffer D, Salameh A, Hagendorff A (2006). Therapie des Vorhofflimmerns. In: Lewalter T, Rationale Arrhythmiebehandlung - Ein Paradigmenwechsel. (S. 115-123), Darmstadt: Steinkopf Verlag.
     
  653. Salameh A (2006). Life cycle of connexins: regulation of connexin synthesis and degradation. In: Dhein S, Cardiovascular gap junctions. (S. 57-70), Basel: Karger Verlag.
     
  654. Voigt H, Conradi E (2006). Die Bedeutung der Inneren Medizin, Geriatrie und Dermatologie. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 15-24), Zwickau: Verlag Wissenschaftliche Skripten.
     
  655. Voigt H, Conradi E, Mendel J (2006). Herz-Kreislauferkrankungen. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 29-103), Zwickau: Verlag Wissenschaftliche Skripten.
     
  656. Voigt H, Mendel J, Conradi E (2006). Krankheiten der Atmungsorgane. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 105-157), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  657. Voigt H, Conradi E (2006). Krankheiten des Verdauungssystems. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 215-278), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  658. Voigt H, Conradi E (2006). Störungen des Stoffwechsels und der inneren Sekretion. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 279-317), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  659. Conradi E, Voigt H (2006). Erkrankungen der Niere und Harnwege. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 319-340), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  660. Voigt H, Mendel J (2006). Blutkrankheiten und Blutgerinnungsstörungen. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 341-352), Zwickau: Verlag Wissenschaftliche Skripten.
     
  661. Voigt H, Conradi E, Mendel J (2006). Besonderheiten des alternden Menschen-Bedeutung der Geriatrie. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 353-374), Zwickau: Verlag Wissenschaftliche Skripten.
     
  662. Conradi E, Voigt H (2006). Infektionskrankheiten-Einführung. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 375-391), Zwickau: Verlag Wissenschaftliche Skripten.
     


    663. 2005


  663. Scheid R, Voigt H (2005). [Arterial hypertension and dementia] Nervenarzt, 76(2), 143-153.
     
  664. Hagendorff A, Pfeiffer D (2005). [Echocardiographic functional analysis of patients with rheumatoid arthritis and collagen diseases] Z Rheumatol, 64(4), 239-248.
     
  665. Teich N, Engelmann L, Pfeiffer D (2005). [Resuscitation by laypersons: lack of knowledge of first-aid measures in Germany] Dtsch Med Wochenschr, 130(48), 2759-2762.
     
  666. Salameh A, Mühlberg K, Schneider P, Dhein S, Pfeiffer D (2005). Differential regulation of gap junction proteins connexin 40 and connexin 43 in cardiomyocytes Int J Pharmacol, 1(1), 44-54.
     
  667. Salameh A, Dhein S (2005). Pharmacology of Gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta, 1719(1-2), 36-58.
     
  668. Gessner C, Guttler A, Hammerschmidt S, Pfeiffer D, Wirtz H (2005). [Rare cause of pectangina after coronary artery surgery] Internist (Berl), 46(8), 913-916.
     
  669. Wirtz HR (2005). [Chronic bronchitis, COPD] Internist (Berl), 46(2), 175-92.
     
  670. Lemke B, Nowak B, Pfeiffer D (2005). Leitlinien zur Herzschrittmachertherapie. Z Kardiol, 94(10), 704-720.
     
  671. Wiedmann M, Hagendorff A, Bohm R, Schulz T, Mossner J, Caca K (2005). Malignant oesophago-pleuro-pericardial fistula in a patient with oesophageal carcinoma. Z Kardiol, 94(6), 411-414.
     
  672. Fehske W, Buck T, Hagendorff A, von Bardeleben RS, Voelker W, Heinemann S (2005). [Quality assurance in echocardiography. Three-level system in formation and qualifying and concept of an external quality review] Z Kardiol, 94(1), 61-73.
     
  673. Thiele H, Engelmann L, Elsner K, Kappl MJ, Storch WH, Rahimi K, Hartmann A, Pfeiffer D, Kneissl GD, Schneider D, Moller T, Heberling HJ, Weise I, Schuler G (2005). Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J, 26(19), 1956-1963.
     
  674. Mende L, Bohm R, Regenthal R, Klein N, Grond S, Radke J (2005). [Cardiac arrest caused by an ecstasy intoxication.] Anasthesiol Intensivmed Notfallmed Schmerzther, 40(12), 762-765.
     
  675. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfel (2005). Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J, 26(3), 523-548.
     
  676. Emmrich P, Ogunlade V, Gradistanac T, Daneschnejad S, Koch MC, Schober R (2005). [Facioscapulohumeral muscle dystrophy and heart disease] Z Kardiol, 94(5), 348-354.